{% extends "cannula/report_base.html" %}

{% load staticfiles %}

{% block title %}RHITES-EC Performance Summary (October 2020 – September 2021){% endblock %} 
{% block heading %}
<h1 align="center">RHITES-EC Performance Summary (October 2020 – September 2021)</h1> {% endblock %} {% block datacell %}
<td class="w3-right-align Good 0_2_4_none_red_green_yellow none_0_light-green"></td>
{% endblock %}

{% block content %}
<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">

</head>

<body lang=en-UG link=blue vlink="#954F72" style='word-wrap:break-word'>

<div class=WordSection1>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0 width="101%"
 style='width:101.3%;margin-left:-4.75pt;border-collapse:collapse;border:none'>
 <thead>
  <tr style='height:30.25pt'>
   <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
   background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:30.25pt'>
   <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:
   "Gill Sans MT",sans-serif'>CDCS Links1 </span></b></p>
   </td>
   <td width="18%" style='width:18.62%;border:solid windowtext 1.0pt;
   border-left:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;
   height:30.25pt'>
   <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><b><span
   lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
   color:black'>Results2 </span></b></p>
   </td>
   <td width="7%" style='width:7.74%;border:solid windowtext 1.0pt;border-left:
   none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:30.25pt'>
   <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
   line-height:normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:
   "Gill Sans MT",sans-serif;color:black'>Baseline value (2016)</span></b></p>
   </td>
   <td width="6%" style='width:6.2%;border:solid windowtext 1.0pt;border-left:
   none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:30.25pt'>
   <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
   line-height:normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:
   "Gill Sans MT",sans-serif;color:black'>FY 21 Target</span></b></p>
   </td>
   <td width="6%" style='width:6.2%;border:solid windowtext 1.0pt;border-left:
   none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:30.25pt'>
   <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
   line-height:normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:
   "Gill Sans MT",sans-serif;color:black'>Q1</span></b></p>
   </td>
   <td width="6%" style='width:6.2%;border:solid windowtext 1.0pt;border-left:
   none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:30.25pt'>
   <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
   line-height:normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:
   "Gill Sans MT",sans-serif;color:black'>Q2</span></b></p>
   </td>
   <td width="6%" style='width:6.86%;border:solid windowtext 1.0pt;border-left:
   none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:30.25pt'>
   <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
   line-height:normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:
   "Gill Sans MT",sans-serif;color:black'>Q3</span></b></p>
   </td>
   <td width="5%" style='width:5.48%;border:solid windowtext 1.0pt;border-left:
   none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:30.25pt'>
   <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
   line-height:normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:
   "Gill Sans MT",sans-serif;color:black'>Q4</span></b></p>
   </td>
   <td width="8%" valign=top style='width:8.94%;border:solid windowtext 1.0pt;
   border-left:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;
   height:30.25pt'>
   <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><b><span
   lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
   color:black'>FY21 Annual Actual</span></b></p>
   </td>
   <td width="24%" style='width:24.32%;border:solid windowtext 1.0pt;
   border-left:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;
   height:30.25pt'>
   <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><b><span
   lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
   color:black'>Comment</span></b></p>
   </td>
  </tr>
 </thead>
 <tr style='height:9.4pt'>
  <td width="6%" valign=top style='width:6.66%;border:solid windowtext 1.0pt;
  border-top:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:9.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><b><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></b></p>
  </td>
  <td width="93%" colspan=11 valign=top style='width:93.34%;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:9.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><b><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Enhanced prevention and treatment of HIV, malaria, and other
  epidemics among the most vulnerable populations</span></b></p>
  </td>
 </tr>
 <tr style='height:6.1pt'>
  <td width="6%" valign=top style='width:6.66%;border:solid windowtext 1.0pt;
  border-top:none;background:#FBE4D5;padding:0in 5.75pt 0in 5.75pt;height:6.1pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><b><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></b></p>
  </td>
  <td width="93%" colspan=11 valign=top style='width:93.34%;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:#FBE4D5;padding:0in 5.75pt 0in 5.75pt;height:6.1pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><b><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Malaria prevention, Diagnosis and Treatment Interventions Scaled
  Up</span></b></p>
  </td>
 </tr>
 <tr style='height:40.95pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:40.95pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 1.3, Sub-IR 1.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.95pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Proportion of OPD attendees that were diagnosed as malaria cases</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.95pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>45%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:40.95pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>35%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:40.95pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>44.7% (493,264/1,155,143</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:40.95pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>44.8% (508,216/1,133,907)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.95pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>44% (532,282/1,216,768)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.95pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>40%
  (330,617/821,096)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.95pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>44%
  (1,884,266/4,334,327)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.95pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Malaria
  contribution towards OPD attendance in FY21 averaged at 44% above the
  projected target of 35%. The vast water bodies coupled with human economic
  activities including rice growing and sugar cane growing that is associated
  with stagnant water continues to contribute to the vast mosquito breeding
  grounds resulting into high malaria burden in the East Central region.  Only
  3 districts of Bugiri, Namutumba, Buyende had annual average of malaria
  burden less than 40% of the annual outpatient attendance. The relatively
  lower burden is probably due to Indoor residual spraying supported by PMI
  Vector Link in Namutumba and Bugiri districts. Jinja City being more urban
  had the lowest malaria burden at 17% probably because individuals in urban
  setting are more likely to take up malaria prevention measures like use of
  LLINs coupled with better housing facilities screened from mosquitoes than the
  rural population.</span></p>
  </td>
 </tr>
 <tr style='height:58.0pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:58.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 1.3, Sub-IR 1.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:58.0pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Malaria positivity rate (% of OPD cases who test positive using
  either microscopy or malaria rapid diagnostic tests (mRDTs) compared to the
  number of tests done)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:58.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>42%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:58.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>41%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:58.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>55.6% (441827/794,792)</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:58.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>60.4% (453,937/751,066)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:58.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>58% (471,552/808,815)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:58.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>51%
  (289,154/565,250)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:58.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>57%
  (1,658,948/2,916,944)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:58.0pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>The
  annual average malaria positivity as measured by the percentage of patients
  who test positive on either malaria rapid diagnostic test or malaria
  microscopy test was 57% </span><span lang=EN-US style='font-size:9.0pt;
  font-family:"Gill Sans MT",sans-serif'>(1,658,948/2,916,944)</span><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>.
  Jinja City followed by Bugiri district had the lowest malaria positivity due
  to better housing facilities with screens against mosquitoes and Indoor
  residual spraying respectively</span></p>
  </td>
 </tr>
 <tr style='height:24.6pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:24.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 1.3, Sub-IR 1.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:24.6pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Suspected malaria cases tested for malaria at OPD</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:24.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>60%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:24.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>95%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:24.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>102.6% (794,792/774540)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:24.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>96% (751,066/783,567)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:24.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>95% (808,815/853,630)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:24.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>106%
  (565,250/533,728)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:24.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>99%
  (2,916,944/2,955,752)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:24.6pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Excellent
  performance on this indicator over the last 4 quarters with an annual average
  of 99%. The good performance is attributed to the onsite support to health
  facilities during clinical audits, onsite clinical mentorship, and training
  of health workers on Integrated Malaria Management. However, the performance
  slightly surpasses the 100% in FY21Q1 and FYQ4.  The numerator for this
  indicator looks at the total number of tests done in a facility including
  outpatient cases and inpatient cases in laboratory register while the
  denominator looks at the suspected malaria cases in OPD register and yet some
  patients go directly to the inpatient wards partly explains the performance
  exceeding 100%. In addition, few admitted patients who don’t do well on 1st
  line treatment are offered a repeat malaria test on malaria microscopy to
  find out if they still have malaria parasites.</span></p>
  </td>
 </tr>
 <tr style='height:26.15pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:26.15pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 1.3, Sub-IR 1.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:26.15pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Proportion of malaria cases treated that were confirmed by mRDT
  or microscopy malaria test</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:26.15pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>65%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:26.15pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>95%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:26.15pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>98.3% (484,898/493,264)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:26.15pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>98% (498,394/508,216)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:26.15pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>98% (520,531/532,282)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:26.15pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>96%
  (317,320/330,617)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:26.15pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>97%
  (1,835,204/1,884,266)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:26.15pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Almost
  all the malaria cases treated for malaria had confirmed malaria positive
  results with annual cumulative average at 97%</span></p>
  </td>
 </tr>
 <tr style='height:25.6pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:25.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 1.3, Sub-IR 1.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:25.6pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Proportion of malaria cases confirmed that were appropriately
  treated with antimalarial drugs</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:25.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>60%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:25.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>96%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:25.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><a name="_Hlk62635560"><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>98%
  (1,531,265/1,561,500)</span></a></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:25.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>99.2% (166,104/167,003)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:25.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100% (9,524/9,524)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:25.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>99.4%
  (21,797/21928)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:25.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>99%
  (181,440/183,481)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:25.6pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Performance
  well above the targeted performance ranging from 98% in FY21Q1 to 99.2%,
  100%) and 99.4% in FY21Q2, FY21Q3 and FY21Q4 respectively. The excellent
  performance is attributable to onsite technical support to the health
  facilities and weekly sharing of performance dashboards and deliberately
  targeting the poorest performing facilities for support.</span></p>
  </td>
 </tr>
 <tr style='height:26.4pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:26.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 1.3, Sub-IRs 1.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:26.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of patients with negative results but treated for
  malaria</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:26.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>44%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:26.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>10%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:26.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>3.6% (8,649/238,809)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:26.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1.6% (3,541/219,598)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:26.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1.9% (4,730/249,322)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:26.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>2.7%
  (4,605/169,769)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:26.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>2%
  (17,967/883,968)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:26.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Very
  few cases with negative results were treated for malaria. </span></p>
  </td>
 </tr>
 <tr style='height:9.75pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:9.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><a name="_Hlk22978275"><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>IR 1.3, Sub-IRs
  1.3.1 and 1.3.2</span></a></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:9.75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of pregnant women receiving free ITNs at facilities</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:9.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>66%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:9.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>85%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:9.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><a name="_Hlk62547796"><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>64.5% (35174/54546)</span></a></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:9.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><a name="_Hlk70191470"><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>38% (22,685/59,567)</span></a></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:9.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>54% (30,188/55,809)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:9.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>35%
  (18,396/52,013)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:9.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>48%
  (107,511/222,021)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:9.75pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Modest
  performance on this indicator with annual average of 48%. In this reporting
  period only 77,300 LLINs received compared to 222,021 pregnant women
  registered for ANC1 Visit.</span></p>
  </td>
 </tr>
 <tr style='height:14.35pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:14.35pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 1.3, Sub-IR 1.3.1,</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:14.35pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Average stock out rate of ITNs at healthcare facilities</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:14.35pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>60%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:14.35pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>15%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:14.35pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>19.7%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:14.35pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>59%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:14.35pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;50%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:14.35pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>20%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:14.35pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>37.2%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:14.35pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Supply
  of ITNs during FY21Q4 decreased the stock out rate by 30%.</span></p>
  </td>
 </tr>
 <tr style='height:15.6pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:15.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 1.3, Sub-IRs 1.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:15.6pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of pregnant women who received 2 or more doses of
  IPTp for malaria</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:15.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>47.9%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:15.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>79%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:15.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>65.9% (35970/54546)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:15.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>70.5% (42,023/59,567)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:15.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>74% (41,293/55,809)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:15.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>78%
  (40,454/52,013)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:15.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>79%
  (176,024/222,021)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:15.6pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>There
  has been progressive improvement on this indicator. The cumulative annual
  average was 79% equivalent to the projected national and project target.
  Support to districts and healthcare facility teams to address knowledge and
  skills gaps through trainings, clinical audits and mentorships, support
  supervision, supporting functionality of IPTp DOTs corners at every facility
  that offers ANC contributed greatly to the observed performance. In addition,
  weekly stock monitoring of Fansidar to inform redistributions from
  over-stocked sites to under-stocked sites and creating demand creation at
  community level through community dialogues, radio talk shows, stakeholders,
  and community sensitizations through home visits by VHTs have positively
  contributed to the observed improvement.</span></p>
  </td>
 </tr>
 <tr style='height:42.05pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:42.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 1.3, Sub-IRs 1.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:42.05pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of pregnant women who received 3 or more doses of IPTp
  for malaria</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:42.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>23%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:42.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>49%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:42.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><a name="_Hlk62549233"><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>48.5% (26465/54546)</span></a></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:42.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>46.6% (27,735/59,567)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:42.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>51% (28,237/55,809)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:42.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>56%
  (28,855/52,013)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:42.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>50%
  (111,133/222,021)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:42.05pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>The
  annual cumulative performance of 50% slightly surpasses the projected
  performance of 49%. </span></p>
  </td>
 </tr>
 <tr style='height:21.9pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:21.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 3.3 Sub-IR 3.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:21.9pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of health workers trained in case management with
  artemisinin-based combination therapy (ACTs) with USG funds</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:21.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:21.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:21.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:21.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>60</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:21.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:21.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>0</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:21.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>60</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:21.9pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>The
  COVID-19 restrictions negatively impacted on the performance of this
  indicator with only 60 Health care workers being trained compared to the
  planned 100 Health care workers.</span></p>
  </td>
 </tr>
 <tr style='height:20.1pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:20.1pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 1.3, Sub-IRs 1.3.1 and 1.3.2,</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:20.1pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of health workers trained in malaria laboratory
  diagnostics (mRDTs) or microscopy) with USG funds</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:20.1pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:20.1pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:20.1pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:20.1pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>60</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:20.1pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:20.1pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>0</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:20.1pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>60</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:20.1pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>The
  COVID-19 restrictions negatively impacted on the performance of this
  indicator with only 60 Health care workers being trained compared to the
  projected 100 Health care workers</span></p>
  </td>
 </tr>
 <tr style='height:23.35pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.35pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 1.3, Sub-IRs 1.3.1 and 1.3.2,</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.35pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of health workers trained in IPTp with USG funds</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.35pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.35pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.35pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.35pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>60</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.35pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.35pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>0</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.35pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>60</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.35pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>The
  COVID-19 restrictions negatively impacted on the performance of this
  indicator with only 60 Health care workers being trained compared to the
  planned 100 Health care workers</span></p>
  </td>
 </tr>
 <tr style='height:18.75pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:18.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 1.3, Sub-IRs 1.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Average stock out rate of mRDTs at healthcare facilities</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>45%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>10%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>14.90%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>23%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>27.1%&nbsp;</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>18%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>20.8%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.75pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>NMS
  Cycle 1 deliveries coupled with the honoring of back orders contributed to a
  9.1% decrease in stock outs by end of FY21Q4.</span></p>
  </td>
 </tr>
 <tr style='height:14.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:14.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 1.3,   Sub-IRs 1.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:14.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Average stock out rate of Coartem at healthcare facilities</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:14.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>44%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:14.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>10%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:14.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>18.30%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:14.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>25%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:14.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>27.5%&nbsp;</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:14.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>19%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:14.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>22.5%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:14.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Delivery
  of equivalent quantities of AL 6x4 for AL 6x2 and AL 6x3 during FY21Q4
  greatly contributed to an 8.5% decrease in stock outs.</span></p>
  </td>
 </tr>
 <tr style='height:8.5pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:8.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 1.3,   Sub-IRs 1.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:8.5pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Average stock out rate of Fansidar at the healthcare facilities</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:8.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>51%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:8.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>10%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:8.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>13.70%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:8.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>13%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:8.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;25.3%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:8.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>12%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:8.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>16%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:8.5pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>NMS
  Cycle 1 deliveries resulted in availability at health facilities during
  FY21Q4 thus contributing to 13.3% decrease in stock outs</span></p>
  </td>
 </tr>
 <tr style='height:13.0pt'>
  <td width="9%" colspan=3 valign=top style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:13.0pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><b><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></b></p>
  </td>
  <td width="90%" colspan=9 valign=top style='width:90.54%;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:13.0pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><b><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Uptake of Reproductive, maternal, newborn, child, and adolescent
  health (RMNCAH) services scaled up</span></b></p>
  </td>
 </tr>
 <tr style='height:46.7pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:46.7pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.1Sub-IRs 2.1.2,</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>2.1.3, 2.14,</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:46.7pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of pregnant women who used ANC provided by skilled
  health personnel, for reasons related to pregnancy (ANC first visit coverage)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:46.7pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>97.8%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:46.7pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>95%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:46.7pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>94.5% (54,492/57,638)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:46.7pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>103.3</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>(59,555/57,638)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:46.7pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>96.8% (55,809/57,640)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:46.7pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>90.2%
  (52,013/57,640)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:46.7pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>96.2%
  (221,869/</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>230,558)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:46.7pt'>
  <p class=MsoNormal style='margin-top:0in;margin-right:2.85pt;margin-bottom:
  0in;margin-left:0in;line-height:normal'><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>There was good performance
  on ANC 1 coverage (above the 95% annual FY21 target) averaging at 96.2%.</span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:2.85pt;margin-bottom:
  0in;margin-left:0in;line-height:normal'><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif'>During FY21, seven districts
  (Buyende, Iganga, Jinja, Kaliro, Kamuli, Namayingo and Jinja City) attained
  the 95% target while Luuka district had the lowest performance at 79.8%. </span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:2.85pt;margin-bottom:
  0in;margin-left:0in;line-height:normal'><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif'>The good performance during the
  year is attributed to the demand creation activities (ANC trigger events like
  Family Life schools, community mobilization activities by VHTs, home care
  groups). Transport cost, long waiting time, rationing of days over which ANC
  services are provided, few health workforces, still exist as barriers to ANC
  attendance in the region.</span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:2.85pt;margin-bottom:
  0in;margin-left:0in;text-align:justify;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>In
  FY22, RHITES-EC will continue engaging the DHT, facility staff and
  communities to have ANC services accessible daily at health facilities while
  maintaining efficient clinic flow amidst restoring dignity of women, improved
  attendance to duty, work with VHTs and CSOs to adopt good ANC practices.
  RHITES-EC will provide targeted technical support to health facilities and
  communities in the poorly performing sub counties.</span></p>
  </td>
 </tr>
 <tr style='height:35.5pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:35.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR2.1, Sub-IRs 2.13, 2.1.4</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:35.5pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of pregnant women attending 1st ANC visit within the
  1st trimester</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:35.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>21%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:35.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>40%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:35.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>29.8%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>(17,153/57,638)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:35.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>33.8% (19,499/57,638)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:35.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>32.3% (18,611/57,640)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:35.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>29.4%
  (16,944/57,640)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:35.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>31.3%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>(72,207/230,558)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:35.5pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Averagely
  31.3% (below 40% target) of women attending ANC services came in the 1<sup>st</sup>
  three months of their pregnancy. Buyende, Kamuli and Jinja City achieved the
  annual 40% target.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Sub
  counties in the rural areas served by lower-level facilities specifically HC
  IIs performed sub-optimally given the low staffing, inadequate supplies,
  limited days for which ANC services are offered and minimal investigative
  capacity for early pregnancy amidst barriers to timeliness of ANC service
  uptake.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>In FY22, RHITES-EC will work with the </span><span lang=EN-GB
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>USAID SBC
  Activity to </span><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>strengthen the work by VHTs in identification, line listing and
  following up of pregnant women while carrying out integrated outreaches in
  the hard-to-reach areas, community dialogue sessions while facility teams
  will be guided on the new ANC service delivery models. </span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:111.55pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:111.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR2.1, Sub-IRs 2.13, 2.1.4</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:111.55pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of pregnant women attending 1st ANC visit within the 1st
  trimester (indicator in PRS with pre-determined targets)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:111.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:111.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>90,030</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:111.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>17,153</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:111.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>19,499</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:111.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>18,611</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:111.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>16,944</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:111.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>80.2%
  (72,207/90,030)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:111.55pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>The
  number of women attending ANC within the 1st trimester reached 80.2% of the
  annual target by end of FY21.  This good performance during the year, was due
  to support by the team on ANC trigger events</span><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>,
  mentorship to facilities on integration of pregnancy screening by clinicians
  at OPD, guidance of facility teams on RBF use to attract mothers to
  facilities amidst the COVID-19 restrictions that affected gathering of women
  during outreaches, travel of women to health facilities, and fear of
  contracting COVID 19 by both health workers and community members.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>In
  FY22, RHITES-EC will continue to use mass media to sensitize communities on
  early signs of pregnancy, early health seeking behaviours, conduct community
  mobilization using several approaches for timely antenatal care visits. </span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red;background:yellow'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR2.1, Sub-IRs 2.13, 2.1.4</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of pregnant women who attended ANC provided by skilled
  health personnel (ANC 1st visit coverage) (indicator in PRS with
  pre-determined targets)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>225,074</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>54,492</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>59,555</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>55,809</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>52,013</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>98.6%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>(221,869/225,074)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal style='margin-top:0in;margin-right:2.85pt;margin-bottom:
  0in;margin-left:0in;line-height:normal'><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>There was good
  performance against the annual target on the number of women attending
  antenatal for the first time. A total of 221,869 pregnant women of the
  targeted 225,074, attended ANC under skilled health personnel during the year
  FY21, giving a 98.6% achievement on annual target. </span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:2.85pt;margin-bottom:
  0in;margin-left:0in;line-height:normal'><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:2.85pt;margin-bottom:
  0in;margin-left:0in;line-height:normal'><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>In FY22, RHITES-EC
  will continue implementing ANC trigger events, work with facility teams to
  incorporate feedback from client satisfaction and strengthen integration of
  screening for early pregnancy signs into services at all entry points e.g.
  OPD, HIV clinics, Immunization posts etc., improve use of hCG kits.</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR2.1, Sub-IRs 2.1.2,</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of women who used ANC services provided by skilled
  health personnel for reasons related to pregnancy 4 times during pregnancy
  (ANC 4th visit coverage)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>66%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>43</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>43.8% (25,258/57,638)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>47.0% (27,097/57,638)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>48.2% (27,811/57,640)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>48.1%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>(27,730/57,640</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>46.8%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>(107,896/230,558)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal style='margin-top:0in;margin-right:1.95pt;margin-bottom:
  0in;margin-left:0in;line-height:normal;vertical-align:baseline'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>There
  was good performance on the proportion of women attending ANC services for the
  4<sup>th</sup> time at 46.8% in FY21 (above the 43% target).</span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:1.95pt;margin-bottom:
  0in;margin-left:0in;line-height:normal;vertical-align:baseline'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Good
  performance was obtained across the four quarters of the year. Seven of the
  12 districts met the 43% target in the year with performance across districts
  ranging from 33.7% (Mayuge) to 71% (in Jinja City). Facility staff
  mentorships on appointment scheduling, health education on repeated seeking
  of services and community engagements on service uptake were conducted.
  However, barriers to continuity in service uptake including long waiting time
  given the few days for which ANC services are available, poor appointment
  scheduling as a way of reducing client load, inadequate client knowledge on
  benefits for more ANC visits, transport challenges and restrictions during
  the COVID-19 pandemic affected the 4th ANC visits.  </span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>In FY22 RHITES-EC will continue to support implementation of
  activities that lead to increased reattendances of antenatal services by
  pregnant women.</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.2 Sub-IRs 2.2.1 and 2.2.4</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of women who attended ANC provided by skilled health
  personnel for reasons related to pregnancy at least 4 times during pregnancy
  (ANC 4th visit coverage) (indicator in PRS with pre-determined targets)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>75,162</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>101,876</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>25,258</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>27,097</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>27,811</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>27,730</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>106%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>(107,896/101,876)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal style='margin-top:0in;margin-right:1.95pt;margin-bottom:
  0in;margin-left:0in;line-height:normal;vertical-align:baseline'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>The number of women attending at least 4 ANC visits gradually
  increased across all the 4 quarters of FY21, giving a 106% achievement on
  annual target by end of FY21.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>To
  further increase the number of women attending health facilities for the 4
  minimum ANC visits and recommended 8 contacts, RHITES-EC will continue
  implementing interventions geared towards improving 1<sup>st</sup> trimester
  ANC attendance, timely and repeated / scheduled ANC and roll out of the New
  ANC delivery models while maintaining the COVID-19 SOPs and IPC guidelines.</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.1 Sub-IRs</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>2.1.1,2.1.2,2.1.3, IR 2.2 Sub-IR and 2.2.4</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of institutional deliveries (healthcare unit delivery
  rate)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>76.5%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>70%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>57.9% (32,344/</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>55,908)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>61.2% (34,277/</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>55,908</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>63.3%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>(35,368/55,911)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>63.0%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>(35,242/55,911)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>61.3%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>(137,181/223,641)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal style='margin-top:0in;margin-right:1.95pt;margin-bottom:
  0in;margin-left:0in;line-height:normal;vertical-align:baseline'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Fair performance on Institutional delivery rate with an average
  of 61.3% (slightly below 70% target) of the expected deliveries happening at
  health facilities under skilled birth attendants, good progress across the 4
  quarters of the FY21. Performance ranged from 34.5% (Luuka) to 98.2% Jinja
  City with a total of six districts meeting the 70% target. </span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:1.95pt;margin-bottom:
  0in;margin-left:0in;text-align:justify;line-height:normal;vertical-align:
  baseline'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:1.95pt;margin-bottom:
  0in;margin-left:0in;text-align:justify;line-height:normal;vertical-align:
  baseline'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>During the year, MoH upgraded 11 HC IIs in Namutumba, Bugiri,
  Busia, Bugweri and Buyende Districts to HC III with midwives posted;
  RHITES-EC procured and distributed equipment to 6 renovated maternity/ labour
  wards, mentored midwives on care during labour and delivery, supported supply
  chain management, improved the referral processes; implemented action plans
  following findings from client satisfaction surveys,  supported set up of
  emergency units in hospitals within Districts that received Ambulances from
  KOICA/WHO while  communities continued to be mobilized through community
  dialogues to seek maternity services and </span><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>update
  birth preparedness and emergency plans </span><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>amidst
  the COVID-19 Pandemic restrictions.</span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:1.95pt;margin-bottom:
  0in;margin-left:0in;line-height:normal;vertical-align:baseline'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:1.95pt;margin-bottom:
  0in;margin-left:0in;line-height:normal;vertical-align:baseline'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>However, barriers to deliveries at the facilities still do exist
  ranging from sociocultural challenges, limited staffing (numbers and
  availability), subcounties with HC IIs as the highest level of service
  delivery with no midwife, inadequate infrastructure for maternity/delivery
  services with poor sanitation facilities strong existence of traditional
  birth attendants and challenges due to the COVID-19 restrictions.</span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:1.95pt;margin-bottom:
  0in;margin-left:0in;text-align:justify;line-height:normal;vertical-align:
  baseline'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:1.95pt;margin-bottom:
  0in;margin-left:0in;line-height:normal;vertical-align:baseline'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:1.95pt;margin-bottom:
  0in;margin-left:0in;line-height:normal;vertical-align:baseline'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>In FY22, we will continue to work with District, facility and
  community structures to continue line listing and following up pregnant women
  across the MNCH continuum of care, strengthen Respectful maternity care and
  MNH QoC implementation, feedback sessions with the health facility teams to
  address any supply side – specific barriers to facility deliveries while </span><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>community demand creation and mobilization activities by
  community gate – keepers, CSOs and VHTs in selected communities with sub
  optimal performance will be scaled up.</span></p>
  </td>
 </tr>
 <tr style='height:40.9pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:40.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.1 Sub-IRs</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>2.1.1,2.1.2,2.1.3, IR 2.2 Sub-IR and 2.2.4</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.9pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of healthcare facility deliveries (indicator in PRS with
  pre-determined targets)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>107,165</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:40.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>139,783</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:40.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>32,344</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:40.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>34,227</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>35,368</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:white;padding:0in 5.75pt 0in 5.75pt;height:40.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>35,242</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>98.1%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>(137,181/139,783)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:white;padding:0in 5.75pt 0in 5.75pt;height:40.9pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>The number of women delivering at the health facilities under
  skilled attendance increased by 26,030 deliveries from 111,151 in FY20 to
  137,181 by end of FY21 giving a 98.1% achievement on the FY21 annual target.
  This is attributable to the improved quality of services courtesy of onsite
  mentorships and RBF initiative, improved staffing at HC IIs upgraded to HC
  IIIs with midwives to offer maternity services, improved infrastructure in
  some health facilities, and community mobilization alongside good leadership
  both at district, facility, and community levels.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>In FY22, RHITES-EC will continue to support uptake and delivery
  of quality maternity services by women and health workers.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red;background:yellow'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:3.5pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 3.3, Sub-IRs 3.3.1; IR2.2, Sub- IRs 2.2.1; IR2.1, Sub-IRs
  2.1.2, 2.2.4</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of women giving birth who received uterotonics in the
  third stage of labor (or immediately after birth through USG supported
  programs (indicator in PRS with pre-determined targets)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>108,680</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>139,783</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>36,297</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>38,842</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>35,368</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>35,713</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>104.6%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>(146,220/139,783)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>There
  was good performance on this indicator attaining 104.6% on the annual target
  by end of FY21. This is attributed to improved documentation and reporting on
  AMSTL following mentorships, improved supply chain management leading to
  availability of uterotonics (Oxytocin and Misoprostol) with redistribution
  from well stocked to poorly stocked facilities. </span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>In
  FY22, RHITES-EC will continue to work with the district and facility teams to
  maintain the care in prevention of postpartum haemorrhage using uterotonics,
  immediate documentation and reporting on this indicator as learning on stock
  management is scale up, reporting and Oxytocin/EPI integration.</span></p>
  </td>
 </tr>
 <tr style='height:3.15pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:3.15pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR2.1, Sub-IRs 2.1.2, 2.1.3</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.15pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Caesarean section rate</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.15pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>4.4%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.15pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>10%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.15pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>4.1% (2,305/</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>55,908)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.15pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>4.0% (2,233</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>/55,908)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.15pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>4.3%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>2,385/55,911)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.15pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>4.9%
  (2,734/55,911</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.15pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>4.3%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>(9,657/</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>223,641)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.15pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal;vertical-align:
  baseline'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>C-section
  rate improved by a 0.4% point (939 C/sections) from average of 3.9% in FY20
  to 4.3% in FY21 (below the 10% target). Performance ranged from an annual
  average of 0.9% in Buyende to 18% in Jinja City because of several CEmONC
  sites.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal;vertical-align:
  baseline'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal;vertical-align:
  baseline'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>There
  was gradual improvement in the C/Section rate across the 4 quarters of FY21
  with the highest at 4.9% in FY21Q4. Improvements during the year are
  attributable to improved coverage of CEmONC facilities by key cadres
  especially medical officers/ anaesthetic staff, renovation and equipping of
  theatres (Jinja RRH, Kamuli General Hospital, Walukuba HC IV and Mayuge HC
  III), introduction of blood transfusion services at 3 HCIVs, improved
  referral /ambulance system where the region got 7 ambulances from KOICA/WHO
  being coordinated by the Regional Emergency Medical services coordinator.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal;vertical-align:
  baseline'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal;vertical-align:
  baseline'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal;vertical-align:
  baseline'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>However
  the region continues to face a non-consistent CEmONC sites 24/7-hour coverage
  because of human resource gaps, infrastructural challenges, inadequate
  supplies, and stock out of anaesthetic drugs.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal;vertical-align:
  baseline'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal;vertical-align:
  baseline'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>In
  FY22, RHITES-EC will continue to engage the district leadership on
  recruitment of key personnel for a 24/7-hour coverage, mobilization of
  resources for improving infrastructure, work with Jinja RRH to build
  operative skills for facility teams identified with gaps in management of
  obstetric complications. </span></p>
  </td>
 </tr>
 <tr style='height:32.6pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:32.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>R 2.1</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Sub-IRs 2.1.2 and 2.1.3</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:32.6pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Proportion of babies with Birth Asphyxia</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:32.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>3.40%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:32.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1.0%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:32.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>3.6% (1,152/</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>31,788)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:32.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>3.9% (1,298/</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>33,661)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:32.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>3.4% (1,194/34,971)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:32.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>3.5% (1,237/34,778)</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:32.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>3.6%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>(4,881/</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>135,198)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:32.6pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Birth
  asphyxia was at 3.6% by end of FY21 (a 2.6%-point increase above the annual
  target of 1.0%). This was an improvement from 3.9% at end of FY20.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Birth
  asphyxia rates were highest at 9.7% for Hospitals, 6.1% for HC IVs, 4.7% for
  Regional referral and lowest at 1.7% for HC IIIs and HC IIs.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>In
  FY22, RHITES-EC will continue to mentor frontline health workers in
  monitoring of fetal well-being, partograph interpretation for timely and appropriate
  intervention including resuscitation to improve outcomes for babies that born
  asphyxiated.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red;background:yellow'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:61.6pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:61.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.2 Sub-IRs, 2.2.1, 2.2.2 2.2.3, and 2.2.4, IR 3.3, Sub-IR
  3.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:61.6pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of newborns not breathing at birth who were resuscitated
  in USG-supported programs (indicator in PRS with pre-determined targets)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:61.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>946</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:61.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>3,838</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:61.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1,152</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:61.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1298</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:61.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1,194</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:61.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>1,276</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:61.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>123%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>(4,728/</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>3,838)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:61.6pt'>
  <p class=MsoNormal style='margin-top:0in;margin-right:1.95pt;margin-bottom:
  0in;margin-left:0in;line-height:normal'><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif'>There was good performance on
  this indicator during FY21 with 123% (4,728) of the targeted 3,838
  resuscitated (either by suction and stimulation and/or Bag and Mask).</span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:1.95pt;margin-bottom:
  0in;margin-left:0in;line-height:normal'><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:1.95pt;margin-bottom:
  0in;margin-left:0in;line-height:normal'><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif'>During the year, more c</span><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>hildren (4,728) than the targeted (3,838) were born with birth
  asphyxia. </span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:1.95pt;margin-bottom:
  0in;margin-left:0in;line-height:normal'><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif'>During the year,<span
  style='color:black'> mentorships on newborn resuscitation using the Helping
  Babies Breathe (HBB)/ survive curriculum at 123 health facilities were
  conducted while 12 facilities with Newborn care units were mentored on
  advanced resuscitation of severely asphyxiated babies and their management.
  RHITES-EC procured resuscitation equipment (neonatal bag and mask) and
  distributed them to newly renovated maternity wards and Jinja RRH.</span></span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:1.95pt;margin-bottom:
  0in;margin-left:0in;line-height:normal'><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>In FY22, RHITES-EC will continue to provide targeted skills
  building sessions to frontline health workers in facilities with high birth
  asphyxia rates (&gt;5%) and low successful resuscitation rate (&lt;85%). </span></p>
  </td>
 </tr>
 <tr style='height:3.5pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR3.4, Sub-IRs 3.4.4 IR 1.1, Sub-IR 2.1.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Proportion of mothers initiating breastfeeding within 1 hour
  after birth</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>70%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>95%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>96.3% (30,621/</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>31,788)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>92.7% (31,207/</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>33,661)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>93.4% (32,658/34,971)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>94.5%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>(32,874/34,778)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>94.2%
  (94,486/135,198)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal style='margin-top:0in;margin-right:1.95pt;margin-bottom:
  0in;margin-left:0in;line-height:normal;vertical-align:baseline'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>There was good performance on proportion of </span><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>mothers
  that initiated breast feeding within 1 hour of birth at an annual average of
  94.2% (target 95%) ranging from 88.8% in Luuka to 98.6% in Bugiri District.
  Target was not met across all the 4 quarters of FY21.</span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:1.95pt;margin-bottom:
  0in;margin-left:0in;line-height:normal;vertical-align:baseline'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Only
  6 districts met the 95% minimum target. </span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:1.95pt;margin-bottom:
  0in;margin-left:0in;line-height:normal;vertical-align:baseline'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>In
  FY22, RHITES-EC will continue to support health education talks to mothers
  and caretakers by midwives to address the barriers to early initiation of
  breastfeeding and also create early breastfeeding support groups. </span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red;background:yellow'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:3.5pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.2 Sub-IRs, 2.2.1, 2.2.2 2.2.3, and 2.2.4, IR 3.3, Sub-IR
  3.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of newborns who received postnatal care within two days
  of childbirth in USG-supported programs.</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>135,589</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>29,811</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>31,571</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>32,735</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>32,530</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>93.5%
  (126,827/135,589)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal style='margin-top:0in;margin-right:1.95pt;margin-bottom:
  0in;margin-left:0in;line-height:normal;vertical-align:baseline'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>There was good performance on the proportion of live births that
  received postnatal care within 2 days of childbirth at an average 93.5%
  (126,827/135,589) of the annual target.</span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:1.95pt;margin-bottom:
  0in;margin-left:0in;line-height:normal;vertical-align:baseline'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:1.95pt;margin-bottom:
  0in;margin-left:0in;line-height:normal;vertical-align:baseline'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>In FY22, RHITES-EC will continue supporting health facilities to
  implement improved client flow and addressing supply inadequacies for
  complete PNC checks, encouraging a 24hour facility stay, offer PNC checks to
  babies within 6 hours, 24 hours and at discharge, engage VHTs in PNC checks
  at 2 days and referral of those identified with danger signs. </span></p>
  </td>
 </tr>
 <tr style='height:40.9pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:40.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR2.1, Sub-IRs 2.1.2,</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.9pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Proportion of mothers who attended PNC visit at 6 weeks
  postpartum</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>17%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:40.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>46%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:40.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>31.6% (17,643/</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>55,911)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:40.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>33.8% (18,903,</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>55,911)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>36.2% (20,224/55,911)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>36%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>(20,103/55,911)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>34.4%
  (76,873/223,641)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.9pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>The proportion of mothers seeking PNC at 6 weeks increased by a
  10% point from 24.4% in FY20 to an annual average of 34.4% FY21. (target,
  46%)<a name="_Hlk21364444">. Slight improvements across the 4 quarters of the
  year were realized with </a></span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>three
  (Iganga, Jinja and Kamuli) of the 12 districts meeting the 46% <span
  style='color:black'>target. Despite the increase in women receiving care at 6
  weeks, the region still faces weak PNC/EPI integration both at the static and
  outreach settings especially at the lower facilities (HCIIs or HCIIIs) due to
  human resource and infrastructure gaps. </span></span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>In FY22, RHITES-EC will continue to support the integration of
  PNC/EPI services at health facilities while observing the IPC guidelines. </span></p>
  </td>
 </tr>
 <tr style='height:35.1pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:35.1pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.1 Sub-IR 2.1.2 and 2.1.3</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:35.1pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Institutional maternal mortality rate (Per 100,000)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:35.1pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>368</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>/100,000</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:35.1pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100/</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100,000</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:35.1pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>107/</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100,000 </span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>(34/31,788)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:35.1pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>77/</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100,000</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>(26/</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>33,661)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:35.1pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>85.8/100,000 (30/34,971)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:35.1pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>69/</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>100,000</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>(24/34,778)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:35.1pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>84.3/</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>100,000</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>(114/</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>135,198)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:35.1pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>The
  institutional mortality ratio averaged at 84.3/100,000 births in FY21, a
  reduction from 94.6/100,000 live births in FY20.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>The good
  performance is due to improved knowledge and skills of managing obstetric
  complications, implementation of recommendations/ action plans following
  death reviews, increased functionality of CEmONC facilities because of
  increased coverage by key cadres and availability of blood and its products
  and improvements in referral processes from lower health facilities.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>In
  FY22, RHITES-EC will continue to support functionalization of the regional
  referral/ambulance network, carry out targeted BEmONC/CEmONC and MPDSR
  mentorships using the revised Essential Maternal and Newborn Clinical care
  guidelines for Uganda, print copies and distribute to facilities, scale up
  Oxytocin/EPI integration for maintained potency of oxytocin in preventing PPH
  (major cause of maternal mortality). Jinja RRH </span><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>will be
  supported to organize regional review meetings on management of complicated
  cases that were near misses or deaths and learning from them. </span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red;background:yellow'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:25.45pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:25.45pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR2.1, Sub-IRs 2.1.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:25.45pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Proportion of maternal deaths reported which are reviewed</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:25.45pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>13.9%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:25.45pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>90% </span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:25.45pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>97% (33/34)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:25.45pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>96% (25/26)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:25.45pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100% (30/30)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:25.45pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>(24/24)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:25.45pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>98.2% (112/114)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:25.45pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>There
  was good performance on maternal death reviews above the 90% target at an
  annual average of 98.2% in FY21. This performance was noted across the 4
  quarters of FY21 with 100% death review rate in FY21Q3 and FY21Q4.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>The
  good performance is attributed to RHITES-EC support for MPDSR activities
  which include, use of the weekly data on maternal deaths summarized and
  shared by MCHN to follow up and arrange for death reviews, joint death
  reviews especially at lower facilities, mentorships on MPDSR, availing death
  review forms, mentoring records staff at health facilities on death review
  report entry into the DHIS2. </span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>In
  FY22, RHITES-EC will continue engaging the District MPDSR committee and
  facility teams in strengthening quality death reviews and using a QI approach
  to track implementation of recommendations following death reviews. </span></p>
  </td>
 </tr>
 <tr style='height:31.75pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:31.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>R 2.1, Sub-IRs 2.1.2 and 2.1.3</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:31.75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Institutional still births rate</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:31.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>14/1,000</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:31.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>15/1,000</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:31.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>15.6/1,000</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:31.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>15.5/1,000</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:31.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>15.6/1,000</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:31.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>15.1/1,000</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:31.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>15.1/</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>1,000</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:31.75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>The
  region registered significant change in the still birth rate between the FY20
  and FY21 period from 17.5/1,000 deliveries by end of FY20 to 15.1/1000
  deliveries in FY21. (Slightly above 15/1,000 deliveries target.)</span><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'> </span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>During
  FY21, still birth rates were lowest at 14.3/1,000 deliveries in FY21Q2 due to
  the improved care during antenatal, labour and delivery periods.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Rates
  ranged from 5.6/1,000 (in Buyende) to 29.9/1,000 in Jinja City. Macerated
  still births contributed 50.1% of the total still births while fresh still
  births were at 49.9%, a need for us to focus deeply into care during late
  antenatal, labour and delivery periods. </span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>In
  FY22, RHITES-EC will continue supporting facility teams to implement
  improvement processes during ANC (prevent, identify, and manage risk
  factors), active labour monitoring and timely skilled attendance to
  deliveries (normal / operative) while pregnant women will be sensitized and
  mobilised for timely seeking and uptake of services alongside improvement in
  the referral processes. </span></p>
  </td>
 </tr>
 <tr style='height:35.85pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:35.85pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.2, Sub-IRs 2.2.1 and 2.2.4</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:35.85pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Institutional Neonatal Mortality rate (per 1000)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:35.85pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>16/1,000</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:35.85pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>15/1,000</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:35.85pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>5.2/1,000</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:35.85pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>5.26/1,000</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:35.85pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>4.98/1,000</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:35.85pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>5.12/1,000</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:35.85pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>5.13/</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>1,000</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:35.85pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>There
  was a decline in neonatal mortality by 1.1 point from 6.2/1,000 live births
  in FY20 giving an average of 5.13/1,000 live births in FY21(within the
  acceptable target of 15/1,000 live births). Ninety-three percent (</span><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>93</span><span lang=EN-US style='font-size:9.0pt;font-family:
  "Gill Sans MT",sans-serif;color:black'>%) of the neonatal deaths occurred
  within the 1st week of life while 7.0% were in the 8 – 28-day period,
  translating into an institutional early neonatal mortality of 4.77/1,000 live
  births in FY21, a decline from 7.7/1,000 live births in FY20.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>The
  good performance during FY21, is due to improved knowledge and skills among
  health workers following mentorships in resuscitation, provision of essential
  newborn care supplies, KMC and management of the sick newborn with better
  equipped Newborn care units.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>In
  FY22, RHITES-EC will implement the MNH QoC focusing on interventions on the
  most common causes of neonatal deaths especially around labour, delivery, and
  1<sup>st</sup> week of postnatal. Health talks to mothers/ caretakers on care
  for a neonate especially essential newborn care (Breastfeeding, keeping warm,
  cord care, monitoring for danger signs etc) while at home will be emphasized
  to increase adoption of good newborn care practices.</span></p>
  </td>
 </tr>
 <tr style='height:24.6pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:24.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>R 2.1, Sub-IRs 2.1.2 and 2.1.3</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:24.6pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Perinatal mortality rate</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:24.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>2.6%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:24.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>2.0%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:24.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>2.05% (661/</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>32,294)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:24.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>2.02%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>(692/</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>34,190)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:24.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>2.0% (710/35,521)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:24.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>1.98%
  (700/35,311)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:24.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>1.98%
  (2,723/</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>137,276)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:24.6pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Perinatal
  mortality rate was within the acceptable target rate of 2.0% at 1.98% in
  FY21, an improvement from 2.51% in FY20. Rates ranged from 0.69% in Buyende
  to 5.2% in Jinja City. PMR were highest at RRH level at 89/1,000 total birth,
  53.8/1,000 at Hospitals: 22.9/1,000 at HC IV,</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>8.7/1,000
  at HC IIs and lowest 7.1/1,000 total births at HC IIIs</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Still
  births contribution to Perinatal mortality rate was at 76.3% in FY21, an
  increase from 70% in FY20. </span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>In
  FY22, RHITES-EC will continue to offer targeted support to poorly performing
  facilities using QI approach (BABIES matrix, PDSR findings etc.) to address
  poor outcomes of labour and delivery and quality antenatal care.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:129.55pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:129.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR2.2, Sub-IR2.2.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:129.55pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Proportion of perinatal deaths reported that are reviewed</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:129.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>3.8%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:129.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>90%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:129.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>29.5% (195/661)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:129.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>51.0% (353/692)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:129.55pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'> 40.4%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>(287/710)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:129.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>31.1%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>(218/700)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:129.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>42.6%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>(1,159/</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>2,723) 
  </span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:129.55pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>There was a 24.6%-point increase in performance in proportion of
  perinatal deaths that were reviewed during the year from 18% in FY20 to an
  annual average of 42.6% in FY21.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Death review rates were highest in FY21Q2, following redirection
  of the support by the PDSR District roving teams to high burden health
  facilities (mainly CEmONC). RHITES-EC continued to support the district MPDSR
  roving teams with special focus on the Hospitals and HC IVs with a few high
  burden HC IIIs. Rates were highest at 64.7% at Hospitals level and lowest at
  15.7% at RRH.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><i><u><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Challenges in PDSR</span></u></i><i><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>:</span></i></p>
  <p class=MsoListParagraph align=left style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:19.7pt;text-align:left;text-indent:-.25in'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Calibri",sans-serif;
  color:black'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><i><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>underreporting, non-reporting in HMIS 033B (weekly surveillance)
  which guides targeted facility support</span></i></p>
  <p class=MsoListParagraph align=left style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:19.7pt;text-align:left;text-indent:-.25in'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Calibri",sans-serif;
  color:black'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><i><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Late reviews beyond the recommended 7 days</span></i></p>
  <p class=MsoListParagraph align=left style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:19.7pt;text-align:left;text-indent:-.25in'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Calibri",sans-serif;
  color:black'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><i><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>limited knowledge in the ICD-11 coding of perinatal deaths</span></i></p>
  <p class=MsoListParagraph align=left style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:19.7pt;text-align:left;text-indent:-.25in'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Calibri",sans-serif;
  color:black'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><i><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Inadequate perinatal death review forms</span></i></p>
  <p class=MsoListParagraph align=left style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:19.7pt;text-align:left;text-indent:-.25in'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Calibri",sans-serif;
  color:black'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><i><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>non implementation of some of the recommendations following
  death reviews</span></i></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:0in;
  margin-left:1.7pt;line-height:normal'><span lang=EN-US style='font-size:9.0pt;
  font-family:"Gill Sans MT",sans-serif;color:black'>In FY22, RHITES-EC will
  reintroduce the PDSR collaborative and continue support to the PDSR roving
  teams at subdistrict level during which PDSR review processes, mentorships
  sessions to facility teams to track and improve performance will be
  conducted.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red;background:yellow'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.2 Sub-IRs 2.2.1 and 2.2.4</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Proportion of neonates (age 0-28 days) presenting to health
  facilities with sepsis/infections who were <br>
  treated appropriately</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>95%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100% (194/194)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>99.4% (162/163)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>(231/231)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>100%
  (63/63)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>99.8%
  (651/652)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>In FY21, 99.8% (651) of the 652 newborns between 0 – 28 days
  diagnosed with sepsis (as additional data using ODK from 135 health
  facilities) received appropriate treatment. </span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>The good performance is attributed to improved knowledge, and
  skills in management of newborn illnesses along the management cascade (from
  history taking, examination, correct diagnosis, investigations, and
  treatment) following mentorships in IMNCI and newborn health at which
  irrational antibiotic use was addressed hence reducing the stock out days of
  key antibiotics. Improved availability of antibiotics at the facilities
  contributed to the neonates receiving care.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>In
  FY22, RHITES-EC will continue with mentorships of facility teams on
  management of the sick newborn using the National guidelines/protocols.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red;background:yellow'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:39.7pt'>
  <td width="9%" colspan=3 valign=top style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:39.7pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.2 Sub-IRs 2.2.1 and 2.2.4</span></p>
  </td>
  <td width="18%" valign=top style='width:18.62%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:39.7pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of children who received DPT3 vaccine by 12 months of age
  in USG- assisted programs (indicator in PRS with pre-determined targets)</span></p>
  </td>
  <td width="7%" valign=top style='width:7.74%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:39.7pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>5,689</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:39.7pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>163,082</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:39.7pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>45846</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:39.7pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>49307</span></p>
  </td>
  <td width="6%" valign=top style='width:6.86%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:39.7pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>47668</span></p>
  </td>
  <td width="5%" valign=top style='width:5.48%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:39.7pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>45995</span></p>
  </td>
  <td width="8%" valign=top style='width:8.94%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:39.7pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>116%</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:39.7pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><a name="_Hlk70326197"><span lang=EN-US style='font-size:9.0pt;
  font-family:"Gill Sans MT",sans-serif'> DPT3 population coverage through FY21
  averaged 95.6% which is above the recommended target of 90% and comparable to
  94% observed in the FY20. A total of 188816 of infants received DPT3 in FY21
  averaging 116% of the annual target </span></a></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>RHITES-EC
  region through the quarters sustained a coverage performance of above the
  recommended 90% at 99.2%,95.3% 96.2% and 92.8% in FY21 FY21Q1, FY21Q2, FY21Q3
  and FY21Q4 respectively.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Averagely
  all districts obtained above the 90% target through the year except Kamuli
  Jinja and Luuka with the lowest performance in Luuka 76.2%</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>To
  sustain this improvement emphasis was put on targeted data driven
  interventions to improve access and reduce DPT1-DPT3 dropout rates. The
  activities included Microplanning and regular performance evaluation and
  feedback, Outreaches and SBCC and mobilization support to poorly reached
  communities, spot checks and mentorship to poorly performing facilities and
  leveraging on RBF and PHC funds to maximize outcomes.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:34.65pt'>
  <td width="9%" colspan=3 valign=top style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:34.65pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.2 Sub-IRs 2.2.1 and 2.2.4</span></p>
  </td>
  <td width="18%" valign=top style='width:18.62%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:34.65pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of children below one year who have received pentavalent
  vaccine PCV3 (PCV 3 coverage)</span></p>
  </td>
  <td width="7%" valign=top style='width:7.74%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:34.65pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>96.3%</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:34.65pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:34.65pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal;vertical-align:baseline'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>95.7%</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:34.65pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>99.5%</span></p>
  </td>
  <td width="6%" valign=top style='width:6.86%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:34.65pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>96.8%</span></p>
  </td>
  <td width="5%" valign=top style='width:5.48%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:34.65pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>92.1</span></p>
  </td>
  <td width="8%" valign=top style='width:8.94%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:34.65pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>95%</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:34.65pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><a name="_Hlk70328101"><span lang=EN-GB style='font-size:9.0pt;
  font-family:"Gill Sans MT",sans-serif'>The children that received PCV3
  averaged 95% an improvement from 89.5% observed in FY20. Unlike in FY 20
  where there was wide discrepancy between PCV3 at 89% and DPT3 at 95%, in FY21
  the two were comparable at 95.6% and 95% respectively.  This is attributed to
  availability of both antigens and improved documentation and regular
  performance monitoring of both antigens throughout the region. </span></a></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>As
  observed with DPT3 coverage all districts averaged above the 90% coverage
  except for Jinja Kamuli and Luuka with Luuka having the lowest performance at
  77</span><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>.8%</span></p>
  </td>
 </tr>
 <tr style='height:35.1pt'>
  <td width="9%" colspan=3 valign=top style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:35.1pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.2 Sub-IRs 2.2.1</span></p>
  </td>
  <td width="18%" valign=top style='width:18.62%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:35.1pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of children under 1 who received measles vaccination
  (measles vaccination coverage)</span></p>
  </td>
  <td width="7%" valign=top style='width:7.74%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:35.1pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>70.2%</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:35.1pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>85%</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:35.1pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>95.7%</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:35.1pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>95.3%</span></p>
  </td>
  <td width="6%" valign=top style='width:6.86%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:35.1pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>96.1%</span></p>
  </td>
  <td width="5%" valign=top style='width:5.48%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:35.1pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>92%</span></p>
  </td>
  <td width="8%" valign=top style='width:8.94%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:35.1pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>94.8%</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:35.1pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><a name="_Hlk70330997"><span lang=EN-US style='font-size:9.0pt;
  font-family:"Gill Sans MT",sans-serif'>Measles coverage in the region
  averaged 94.8% throughout the year a marked improvement from 84% in FY2020.
  The improved performance was sustained throughout the quarters of the year.
  All districts averaged above the 90% coverage except Mayuge and Luuka
  districts at 88.8% and 81.1% respectively</span></a></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>This
  improved performance is attributed to leveraging on community mobilization
  during child health days across the districts and targeted outreaches to
  hard-to-reach areas with very high dropout rates such as the islands on
  Namayingo and Mayuge and distant areas of Luuka </span><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>district.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:34.9pt'>
  <td width="9%" colspan=3 valign=top style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:34.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.2 Sub-IRs 2.2.1 and 2.2.4</span></p>
  </td>
  <td width="18%" valign=top style='width:18.62%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:34.9pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of children aged under five years (12-59 months) who
  have received a 2nd dose for deworming</span></p>
  </td>
  <td width="7%" valign=top style='width:7.74%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:34.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>25%</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:34.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>80%</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:34.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>129.7%</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:34.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>49.2%</span></p>
  </td>
  <td width="6%" valign=top style='width:6.86%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:34.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>140.8%</span></p>
  </td>
  <td width="5%" valign=top style='width:5.48%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:34.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>24.7%</span></p>
  </td>
  <td width="8%" valign=top style='width:8.94%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:34.9pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>86.1%</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:34.9pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><a name="_Hlk70347517"><span lang=EN-GB style='font-size:9.0pt;
  font-family:"Gill Sans MT",sans-serif'> 2<sup>nd</sup> dose of deworming in
  children under 86.1% surpassed the program target of 80%.  Good performance
  was noted in FY21Q1 and FY21Q3 due to good mobilisation and supplies of
  mebendazole during the October 2020 and April 2021 Child health days.
  Performance dipped in FY21Q2 and FY21Q4 because of COVID 19 upsurge and
  suboptimal integration of 2<sup>nd</sup> dose deworming at facility Level.</span></a></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>In
  FY22, RHITES-EC will continue to support mentorships and documentation and
  reporting towards integration of deworming into routine child health services
  and performance reviews</span><span lang=EN-GB style='font-size:9.0pt;
  font-family:"Gill Sans MT",sans-serif'>.</span></p>
  </td>
 </tr>
 <tr style='height:35.95pt'>
  <td width="9%" colspan=3 valign=top style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:35.95pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.2 Sub-IRs 2.2.1</span></p>
  </td>
  <td width="18%" valign=top style='width:18.62%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:35.95pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percent of children under 5 years receiving two doses of Vitamin
  A</span></p>
  </td>
  <td width="7%" valign=top style='width:7.74%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:35.95pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:35.95pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>55%</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:35.95pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>67%</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:35.95pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>26%</span></p>
  </td>
  <td width="6%" valign=top style='width:6.86%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:35.95pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>59.4</span></p>
  </td>
  <td width="5%" valign=top style='width:5.48%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:35.95pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>21.3%</span></p>
  </td>
  <td width="8%" valign=top style='width:8.94%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:35.95pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>43.6%</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:35.95pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><a name="_Hlk70347005"></a><a name="_Hlk85717330"><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>At 43.6%,
  second dose Vitamin A Supplementation in children under 5 with was suboptimal
  (target 55%). Similar to deworming, better performance was noted in FY21Q1
  and FY21Q3 where mass campaigns for ICHDs happened. However, Vit A
  supplementation was low compared to deworming because of stock outs of Vit A
  in many health facilities during the Child Health days. </span></a></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Integration
  at facility level and documentation remain a challenge. In FY20 </span><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>RHITES-EC
  will continue to provide onsite mentorships, support improvement in
  documentation and reporting,  integration of Vitamin A supplementation into
  routine child health services and performance reviews</span><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>  </span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:14.25pt'>
  <td width="9%" colspan=3 valign=top style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:14.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.2, Sub- <br>
  IRs,2.2.1</span></p>
  </td>
  <td width="18%" valign=top style='width:18.62%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:14.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of cases of child diarrhea treated in USG-assisted
  programs (indicator in PRS with pre-determined targets)</span></p>
  </td>
  <td width="7%" valign=top style='width:7.74%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:14.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>90,000</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:14.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>105838</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:14.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>12239</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:14.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>11957</span></p>
  </td>
  <td width="6%" valign=top style='width:6.86%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:14.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>9297</span></p>
  </td>
  <td width="5%" valign=top style='width:5.48%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:14.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>4515</span></p>
  </td>
  <td width="8%" valign=top style='width:8.94%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:14.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>36%</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:14.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>The
  total number of cases for diarrhea in the region is 38008 meeting only 36% of
  the program target. This is mainly attributed to weaknesses in documentation
  at sites without data clerks. Majority of the sites are HCIIs that constitute
  over 50% of the health facilities. Notably the number of diarrhea cases also
  reduced across the quarters. This reduction in caseloads may be attributed to
  targeted community WASH improvement campaigns in the high burden districts
  coupled with improved hand hygiene from the intensified COVID-19 infection
  prevention campaigns at health facilities and the community </span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Diarrhea
  contribution to under 5 OPD attendance averaged 10.1%, a slight increase from
  9.5% observed in FY20. Across the districts, high burden of diarrhea above 10%
  was observed in 7/12 districts (Bugweri, Jinja, Kaliro, Luuka, Mayuge,
  Namayingo, Namutumba) with highest burden in Bugweri and Namayingo averaging
  at 12.3% and 12.4%. respectively</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Appropriate
  treatment for diarrhea was 99.9%, an excellent and sustained improvement
  across the quarters. The good performance above 90% was noted across all
  districts. This is attributed to availability of ZINC and ORS in the health
  facilities and continued IMNCI mentorship in selected districts and health
  facilities with sub-optimal performance.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>In
  FY22, RHITES-EC will continue to conduct targeted onsite IMNCI mentorships to
  health facilities and community WASH campaigns in poorly performing sub
  counties integrated with IPC interventions. .</span></p>
  </td>
 </tr>
 <tr style='height:3.5pt'>
  <td width="9%" colspan=3 valign=top style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.2, Sub- <br>
  IRs,2.2.1</span></p>
  </td>
  <td width="18%" valign=top style='width:18.62%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:3.5pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of new cases of pneumonia aged under five years. (Under 5
  Pneumonia incidence cases) (indicator in PRS with pre-determined targets)</span></p>
  </td>
  <td width="7%" valign=top style='width:7.74%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>54,991</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>53611</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>8028</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>8976</span></p>
  </td>
  <td width="6%" valign=top style='width:6.86%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>12334</span></p>
  </td>
  <td width="5%" valign=top style='width:5.48%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>4755</span></p>
  </td>
  <td width="8%" valign=top style='width:8.94%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>62%</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:3.5pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'> pneumonia
  incidence cases averaged 64% of the annual target.   Severe cases of
  pneumonia constituted 3.3% of the total pneumonia cases. The total burden of
  pneumonia in the EC region was 6.5% comparable to 5.3% observed in the
  previous quarter. The districts with high burden above 10% included Namutumba
  and Kamuli at 11.1% and 11.8% respectively. There is noted reduction in
  pneumonia cases over the last 2 quarters and this is attributed to observance
  of COVID-19 prevention SOPs.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'> </span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><a name="_Hlk70434909"><span lang=EN-US style='font-size:9.0pt;
  font-family:"Gill Sans MT",sans-serif'>.</span></a></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:46.45pt'>
  <td width="9%" colspan=3 valign=top style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:46.45pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.2, Sub- <br>
  IRs,2.2.1</span></p>
  </td>
  <td width="18%" valign=top style='width:18.62%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:46.45pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Proportion of cases of 2-59 months child pneumonia appropriately
  treated in USG-assisted programs (under 5 pneumonia incidence cases)</span></p>
  </td>
  <td width="7%" valign=top style='width:7.74%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:46.45pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:46.45pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:46.45pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>99.1%</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:46.45pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>99.7%</span></p>
  </td>
  <td width="6%" valign=top style='width:6.86%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:46.45pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>99.5%</span></p>
  </td>
  <td width="5%" valign=top style='width:5.48%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:46.45pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>98.9</span></p>
  </td>
  <td width="8%" valign=top style='width:8.94%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:46.45pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>99.2%</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:46.45pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>In
  FY21Q3, appropriate treatment for pneumonia averaged 99.0% comparable to
  99.7% in the previous quarter. The sustained good performance is attributed
  to the availability of Amoxicillin in facilities, improved stock monitoring,
  and continued IMNCI mentorship to selected health facilities to improve
  health provider knowledge and skills in management of pneumonia.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>.</span></p>
  </td>
 </tr>
 <tr style='height:21.55pt'>
  <td width="9%" colspan=3 valign=top style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:21.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.2</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Sub-IRs 2.2.1 and</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>2.2.4</span></p>
  </td>
  <td width="18%" valign=top style='width:18.62%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:21.55pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Institutional Under-5 mortality rates</span></p>
  </td>
  <td width="7%" valign=top style='width:7.74%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:21.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>64 per 1,000 live births</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:21.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&lt;30/ 1000</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:21.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>5.9</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:21.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>5.3</span></p>
  </td>
  <td width="6%" valign=top style='width:6.86%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:21.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>6.3</span></p>
  </td>
  <td width="5%" valign=top style='width:5.48%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:21.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>5.2</span></p>
  </td>
  <td width="8%" valign=top style='width:8.94%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:21.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>6.0/1000
  live births</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt;height:21.55pt'>
  <p class=MsoNormal style='margin-top:0in;margin-right:.05in;margin-bottom:
  0in;margin-left:0in;text-align:justify;line-height:normal;vertical-align:
  baseline'><a name="_Hlk70347838"><span lang=EN-US style='font-size:9.0pt;
  font-family:"Gill Sans MT",sans-serif'>Institutional under 5 mortality in
  FY21 remained within the acceptable margin of &lt;30/1000 averaging 6.0/ 1000
  live births, a decrease from 6.3 /1000 in FY20. There was noted spike of up
  to 10.1 per 100 live births in FY21Q2 with the first surge in COVID 19
  infections which affected continuity of essential services and as such many
  sick children presented late to the hospitals with very severe disease. </span></a></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>The
  highest mortality rate was at the Jinja RRH and the district hospitals at
  46.1/1000 and at district hospitals 16.2/ 1000 live births. Death from the
  hospitals and the Jinja RRH alone contributed to 62.3% of the deaths in the
  region</span><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>.
  Death from malaria and pneumonia has also reduced over the previous quarters.
  </span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Efforts
  to improve quality of care of sick children in the quarter included.</span></p>
  <p class=MsoListParagraph style='margin-top:0in;margin-right:0in;margin-bottom:
  0in;margin-left:.25in;text-align:justify;text-indent:-.25in'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>-<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Initiating
  death audits at Jinja RRH and Iganga hospital. Major gap noted included, poor
  resuscitation skills among health workers, poor triaging systems for very
  sick children and poor referral network within the region.</span></p>
  <p class=MsoListParagraph style='margin-top:0in;margin-right:0in;margin-bottom:
  0in;margin-left:.25in;text-align:justify;text-indent:-.25in'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>-<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>ETAT
  trainings to high volume sites (the district hospitals with the highest
  contributors to under-5 deaths)</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:21.55pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;background:#F7CAAC;padding:0in 5.4pt 0in 5.4pt;height:21.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="90%" colspan=9 style='width:90.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:#F7CAAC;padding:0in 5.4pt 0in 5.4pt;height:21.55pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Access to and uptake of FP services expanded</span></b></p>
  </td>
 </tr>
 <tr style='height:14.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:14.25pt'><span lang=ES
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'><br
  clear=all style='page-break-before:always'>
  </span>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.1, Sub-IRs 2.1.1, IR 3.3 Sub-IRs 3.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:14.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of USG-assisted community health workers (CHWs) providing
  FP information, referrals, and services</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:14.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:14.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>694</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:14.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>694</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:14.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>694</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:14.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>694</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:14.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>694</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:14.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>694</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:14.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>RHITES EC supported 694 Community Health Workers (CHWs): Busia
  (145), Bugiri (90), Buyende (107), Iganga (120), Namayingo (105), Kaliro
  (10), Luuka (107) and Namutumba (10) to provide FP services in their
  communities. CHWs were facilitated with transport and lunch to submit monthly
  reports to nearby health facilities, pick FP commodities and receive
  mentorship from midwife supervisors. </span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>CHWs dispensed </span><span lang=EN-US style='font-size:9.0pt;
  font-family:"Gill Sans MT",sans-serif;color:black'>701,208<b> </b>(16%) </span><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>contraceptives of the total 4,492,169</span><b><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'> </span></b><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>contraceptive dispensed in Oct 2020 – Sept 2021. </span></p>
  </td>
 </tr>
 <tr style='height:3.5pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.1, Sub-IRs 2.1.1, IR 3.3 Sub-IRs 3.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of USG-assisted service delivery sites providing FP
  counseling and/or services</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100% (HCIIIs and above)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>100%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>100%</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>All 134 USG supported sites provided family planning counselling
  and modern family planning methods. </span></p>
  </td>
 </tr>
 <tr style='height:41.8pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:41.8pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.1, Sub-IRs 2.1.1, IR 3.3 Sub-IRs 3.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:41.8pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of USG supported service delivery points offering any
  modern contraceptive methods</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:41.8pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>134 (HCIIIs and above)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:41.8pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:41.8pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>NA</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:41.8pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>NA</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:41.8pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:41.8pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>NA</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:41.8pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>470</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:41.8pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>Each site should have 5 service points (HIV
  care and treatment, HIV testing, ANC/PNC, PP and KP preventions points). The
  134 sites have </span><span lang=EN-US style='font-size:9.0pt;font-family:
  "Gill Sans MT",sans-serif;letter-spacing:-.1pt'>470<span style='color:black'>
  service delivery points which include 134</span></span><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'> </span><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>HIV Testing points, 132 HIV Care and
  Treatment points, 131 Antenatal Care points, 43 Priority Population
  prevention points and 30 KP prevention points.</span></p>
  </td>
 </tr>
 <tr style='height:22.8pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:22.8pt'><span lang=ES
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black;
  letter-spacing:-.1pt'><br clear=all style='page-break-before:always'>
  </span>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=ES style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>IR 2.1, Sub-IRs 2.1.1 2.1.2., IR 3.3 Sub-IR
  3.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:22.8pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>Number of clients provided with FP Services</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:22.8pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:22.8pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:22.8pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>148,725</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:22.8pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>147,626</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:22.8pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>150,268</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>&nbsp;</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:22.8pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>170,239</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:22.8pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>616,858</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:22.8pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>The number of clients provided with FP
  services has progressively increased </span><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>from 147,626 in
  Jan-Mar to 150,268 in Apr – June then to 170,239 in July – Sept 2021.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>The increase was noted in districts of Busia, Mayuge, Namayingo
  and Jinja City. This was attributed to increased mobilization of clients
  using peers and VHTs, and distribution of emergency FP commodities from JMS. </span></p>
  </td>
 </tr>
 <tr style='height:18.55pt'>
  <td width="9%" colspan=3 rowspan=10 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red;background:lime'>&nbsp;</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of new FP users</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>74,588</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>77,571</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>80,547</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>101,311</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>334,017</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="24%" rowspan=10 style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>The New FP clients have steadily increased
  from 74,588 in Oct – Dec 2020 to 77,571 in Jan – Mar 2021 then to 80,547 in
  April – June 2021 finally to 101,311 in July – Sept 2021. Majority of new FP
  users took injectables (41%), implants (25.9%) and condoms (24.6%). The
  uptake of oral pills, IUDs and natural methods was low at 3.9%, 1.5% and 1.3%
  respectively. </span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:18.55pt'>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Condoms</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>20,341</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>14,530</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>17,212</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>19,357</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>71,440</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:18.55pt'>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IUDs</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1,095</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>871</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1,226</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>1,217</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>4,409</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:18.55pt'>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Implants</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>16,778</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>19,727</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>19424</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>19,211</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>75,140</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:18.55pt'>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Oral Pill</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>3,579</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>7,409</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>2,286</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>2,447</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>11,215</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:18.55pt'>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Injectables</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>31,023</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>32,442</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>27,423</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>28,253</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>119,141</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:18.55pt'>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Female Sterilization</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>226</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>566</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>209</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>405</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>1,406</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:18.55pt'>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Male Sterilization</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>57</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>71</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>47</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>25</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>200</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:18.55pt'>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Natural methods</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>618</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1116</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1,094</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>993</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>3,821</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:18.6pt'>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.6pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Other New Users</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>867</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:18.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>839</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>834</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>929</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:18.6pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>3469</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:8.05pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:8.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.1, Sub-IRs 2.1.1 2.1.2.</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:8.05pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of HIV positive clients provided with FP services for the
  1st time</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:8.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:8.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:8.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1,583</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:8.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1,598</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:8.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1,361</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:8.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>1,423</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:8.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>5,965</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:8.05pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>A total of 5,965 HIV positive clients took
  family planning methods for the first-time during Oct 2020 to Sept 2021.
  Majority of clients came from Jinja city 1008 (17%), Kamuli 925 (16%), Iganga
  664 (11%) and Namayingo 647 (11%), while lowest number was noted in districts
  of Bugweri 91 (2%), Kaliro 142 (2%) and Buyende 190 (3%). </span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:42.05pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:42.05pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=ES style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.1, Sub-IRs 2.1.2., IR 3.3 Sub-IR 3.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:42.05pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><a name="_Hlk527887161"><span lang=EN-US style='font-size:9.0pt;
  font-family:"Gill Sans MT",sans-serif;color:black'>Average stock out rate of
  contraceptive commodities at FP service delivery points</span></a></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:42.05pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>10%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:42.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:42.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>17.3%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:42.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>30%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:42.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>46.6%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:42.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>26%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:42.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>30%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:42.05pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>The district orders placed through Alternative Distribution
  Strategy (ADS) were honored resulting in a 20.6% decrease in stock outs. By
  end of FY21, availability of Male condoms is at 100%; IUDs (99%); Implanon
  NXT (99%); Sayana Press (90%); Depo-provera (72%).</span></p>
  </td>
 </tr>
 <tr style='height:34.8pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:34.8pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.1, Sub-IR 2.1.2,</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:34.8pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of additional USG-assisted CHWs providing FP information
  and/or services during the year</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:34.8pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:34.8pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:34.8pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>172</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:34.8pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:34.8pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:34.8pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>0</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:34.8pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>172</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:34.8pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>No additional CHWs were brought on board in FY21Q4. </span></p>
  </td>
 </tr>
 <tr style='height:3.75pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.1, Sub-IR 2.1.2, 2.1.3</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Couple Years of Protection (CYP)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>304,315</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>NA</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>NA</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>NA</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>NA</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>              
  457,639 </span></p>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:9.6pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  vertical-align:baseline'><span lang=EN-US style='font-size:9.0pt;font-family:
  "Gill Sans MT",sans-serif;color:red;letter-spacing:-.1pt'>&nbsp;</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal style='margin-top:0in;margin-right:3.8pt;margin-bottom:
  0in;margin-left:0in;line-height:normal'><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif;color:black;letter-spacing:-.1pt'>The
  CYP for RHITES EC region increased from 341,673 in Oct 2019 – Sept 2020 to
  457,639 in Oct 2020 to Sept 2021. </span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:3.8pt;margin-bottom:
  0in;margin-left:0in;line-height:normal'><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif;color:black;letter-spacing:-.1pt'>The
  national CYP estimation for FY20 is </span><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>4,700,000 of which
  RHITES EC region expects to contribute 521,160. There was 87.8% (457,639 /
  521160) achievement of CYP dispensed in RHITES EC during Oct 2020 – Sept
  2021. </span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:3.8pt;margin-bottom:
  0in;margin-left:0in;line-height:normal'><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:0in;margin-right:3.8pt;margin-bottom:
  0in;margin-left:0in;line-height:normal'><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif;color:black;letter-spacing:-.1pt'>This
  was attributed to targeted mentorship of health workers with challenges in
  provision of FP services especially long-term methods, collaborating with
  other FP implementing partners (RHU, Marie stopes, and JHPIEGO’s The<i>
  Challenge Initiative</i> (TCI)) to conduct FP outreaches for long and
  permanent methods and facilitated VHTs to mobilize clients while other FP
  implementing partners provided services.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:3.75pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.1, Sub-IR 2.1.2,</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of people trained in FP service provision</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>0</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>0</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:0in;margin-top:
  0in;text-align:justify;line-height:normal'><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif'>Conducted targeted mentorship of
  Family Planning (FP) service providers in 120 RBF supported health facilities
  while observing COVID-19 SOPS. A total of 326 FP service providers were
  mentored on high impact FP practices.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:0in;margin-top:
  0in;text-align:justify;line-height:normal'><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>Conducted targeted
  mentorship of</span><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'> 173</span><span lang=EN-US style='font-size:9.0pt;font-family:
  "Gill Sans MT",sans-serif;color:black'> FP providers in 82 health facilities
  of Luuka, Namayingo, Mayuge, Namutumba, Bugiri and Busia on documentation of
  family planning services</span><span lang=EN-US style='font-size:9.0pt;
  font-family:"Gill Sans MT",sans-serif;color:black'>.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:0in;margin-top:
  0in;line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:
  "Gill Sans MT",sans-serif;color:black'>Conducted targeted mentorship of 42
  health workers from 24 HCIIs in 5 districts of Jinja, Bugiri, Kamuli,
  Namayingo and Mayuge on using revised data family planning tools.</span></p>
  </td>
 </tr>
 <tr style='height:3.75pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="90%" colspan=9 style='width:90.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:0in;margin-top:
  0in;line-height:normal'><b><span lang=EN-US style='font-size:9.0pt;
  font-family:"Gill Sans MT",sans-serif;color:black'>Access to and uptake of
  nutrition services increased</span></b></p>
  </td>
 </tr>
 <tr style='height:3.75pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.2 Sub-IRs 2.2.2, IR 3.3, Sub-IRs 3.3.4</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of individuals receiving nutrition-related professional
  training through USG-supported programs</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>40</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>20</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>0</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>0</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>No
  trainings conducted during the year. The project prioritized data driven
  targeted support to underperforming facilities and communities during the
  year.</span></p>
  </td>
 </tr>
 <tr style='height:3.75pt'>
  <td width="9%" colspan=3 rowspan=2 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.2 Sub-IRs 2.2.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Proportion of people that accessed nutritional assessment and
  counselling services (NACS) at OPD</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>15%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>45%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>51.2%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>52%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>47.5%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>43.4%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>48.7%</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.75pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>NACS
  at OPD has been sustained above annual target over 3 quarters attributed to
  timely targeted data driven virtual and physical support to identified
  underperforming facilities each quarter.  However, staff absenteeism at the
  key contact points and subsequent increased workload for the few staff
  present affects performance. </span></p>
  </td>
 </tr>
 <tr style='height:45.85pt'>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:45.85pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Proportion of Children 6-59 months who received nutritional
  assessment and categorization at facility level</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:45.85pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>15%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:45.85pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>45%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:45.85pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>62%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:45.85pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>61.2%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:45.85pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>60.2%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:45.85pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>55.7%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:45.85pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>59.8%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:45.85pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Owing
  to targeted data driven site support initiatives to underperforming
  healthcare facilities, NACS among children 6 – 59 months averaged at 60%
  (603,229/1,008,190) and above annual target (45%) with district performance
  variations. Ten districts and Jinja city surpassed annual target while
  performance was highest in Iganga (84.3%) and lowest in Namayingo (41.2%) and
  Bugiri (40.8%). Targeted site support will continue in FY22 aimed at
  sustaining the FY21 achievements.</span></p>
  </td>
 </tr>
 <tr style='height:40.45pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:40.45pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.2 Sub-IRs 2.2.2, IR 1.3 Sub-IRs 1.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.45pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Proportion of HIV positive patients receiving HIV care services
  whose nutrition status was assessed</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.45pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>87%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:40.45pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>90%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:40.45pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>90.1%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:40.45pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>89.2%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.45pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>95%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.45pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>82.9%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.45pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>89.3%</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.45pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>NACS
  among HIV patients averaged at 89.3%, slightly below annual target (90%);
  highest in Bugweri district (95.7%) while only Busia (83.4%), Jinja district
  (81.4%) and Jinja City (88%) below annual target. The high performance
  observed during the year is attributed to targeted site support and improved
  documentation and reporting by the facilities. Targeted physical and virtual
  support will be continued in FY22.</span></p>
  </td>
 </tr>
 <tr style='height:40.0pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:40.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.2 Sub-IRs 2.2.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.0pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Proportion of children 0 -59months who received nutritional
  assessment and had acute malnutrition</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>5.3%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:40.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>2%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:40.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1.5%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:40.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1.1%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>1.1%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1.7%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  letter-spacing:-.1pt'>1.3%</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:40.0pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>At
  1.3% (7771/594,290), the burden of acute malnutrition among children under
  five years seen at healthcare facilities has been sustained above annual
  target with district performance variations.      The burden is highest in
  Jinja (6.4%) and lowest in Buyende (0.4%). Notably only 5 districts namely
  Bugiri (1.3%), Bugweri (1.7%), Namayingo (1.2%), Namutumba (1.4%) and Jinja
  (6.4%) have burden &gt;1%. Jinja is home to the highest malnutrition referral
  unit (Jinja Regional Referral hospital) that serves other districts within
  and beyond East Central region, thus the exceptionally high burden reported</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>The
  overall low burden is due to data driven targeted community-level prevention
  interventions (such as community dialogues, nutrition care group sessions,
  home-to-home WASH and nutrition improvement campaigns, family life schools)
  implemented during the quarter that contributed to improved household food
  security and dietary intake. </span></p>
  </td>
 </tr>
 <tr style='height:35.05pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:35.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.2 Sub-IRs 2.2.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:35.05pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Proportion of malnourished clients who received nutritional
  supplementary / therapeutic foods</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:35.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>43%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:35.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>60%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:35.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>64%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:35.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>37.7%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:35.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>48.3%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:35.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>55.6%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:35.05pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>55.5%</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:35.05pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Access
  to supplementary/therapeutic foods by severely malnourished children
  &lt;5years averaged at (741/1,336) 55.5% over the year; increasing from 48.3%
  (FY21Q3) to 55.6% (FY21Q4) as OTC sites were increased from 15 to 27 in
  FY21Q2.  Access to therapeutic foods during the year was highest in Jinja
  (100%), Mayuge (100%), Namayingo (83%), and lowest in Kaliro (1%); largely
  affected by COVID-19 travel restriction that limited access by some eligible
  clients, documentation gaps in some facilities and irregular stock of
  therapeutic foods experienced FY21Q2. RHITES EC will continue collaborating
  with UNICEF and Medical Access Uganda limited (MAUL) to maintain facility
  stocks in FY22 to augment site specific OTC technical support. </span></p>
  </td>
 </tr>
 <tr style='height:3.5pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR3.4, Sub-IRs 3.4.4 IR 1.1, Sub-IR 2.1.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Proportion of mothers initiating breastfeeding within 1 hour
  after birth</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>70%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=ES style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>90%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=ES style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>96.3%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=ES style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>92.7%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=ES style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>92%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=ES style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>92.8%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>92.5%</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Timely
  initiation of breastfeeding averaged at 92.5% (95,421/103,089) and above
  annual target (90%) with 5 districts namely Bugweri (88.5%), Kamuli (89.6%),
  Luuka (86.6%) and Namutumba (86%) slightly below the annual target.  The good
  performance is largely due to improved and sustained health education in
  maternal child health (MCH) units and adherence to newborn care standards
  among midwives and mothers in maternity units.   Underperforming districts
  and facilities will be targeted for support in FY22</span><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;background:yellow'>
  </span></p>
  </td>
 </tr>
 <tr style='height:3.5pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.2 Sub-IRs 2.2.2, 2.2.4</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Proportion of pregnant and lactating women who received Infant
  and Young Child Feeding (IYCF) counselling</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>22%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>75%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>76.6%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>76.7%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>77.5%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>77.2%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>76.9%</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Commendable
  indicator performance at 76.9% (854,837/1,112,057) with overall district
  average above annual target (75%) but with district performance variations: 
  Highest performance was recorded in Iganga (87.8%) with 5 districts namely,
  Kamuli (74.8%), Busia (74.1%), Jinja (73.9%), Namayingo (71.2%) and Mayuge
  (66.5%) were slightly below annual target. Overall high performance is
  attributed to targeted site support for improved maternal care and adherence
  to quality counseling, documentation, and reporting.</span></p>
  </td>
 </tr>
 <tr style='height:12.55pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:12.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.2 Sub-IRs 2.2.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:12.55pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of children under five (0-59 months) reached by
  nutrition-specific interventions through USG-supported programs</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:12.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>170,000</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:12.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>407,826</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:12.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>301,196</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:12.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>105,058</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:12.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>206,556</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:12.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>109,711</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:12.55pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>720,740</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:12.55pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>A
  total of 720,740 (355,063male; 355,063female) children received vitamin A 1<sup>st</sup>
  dose during the year, surpassing annual target. The achievement is attributed
  to well-coordinated child health days+ (in April 2021 and October 2020), and
  continued supplementation initiatives during the year, coupled with easier
  mobilization and reach for children in communities since all schools were
  closed during the COVID-19 pandemic. Further, sustained stock of vitamin A in
  healthcare facilities and improved documentation contributed to the high
  performance. </span></p>
  </td>
 </tr>
 <tr style='height:16.15pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:16.15pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.2 Sub-IRs 2.2.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:16.15pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of pregnant women reached by nutrition-specific
  interventions through USG-supported programs</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:16.15pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>185,000</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:16.15pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>152,583</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:16.15pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>38,613</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:16.15pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>39,551</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:16.15pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>38,073</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:16.15pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>32,559</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:16.15pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>148,986</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:16.15pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>During
  the year, 148,986 (97.6%) of pregnant women received the recommended minimum
  of 30 iron-folic acid (IFA) tablets at the 1<sup>st</sup> ANC visit. The high
  performance is attributed to sustained stock of iron-folic acid (IFA) tablets
  at all-level facilities, and continued site support to sustain quality
  antenatal care, adherence to IFAS supplementation protocols including
  documentation and reporting. </span></p>
  </td>
 </tr>
 <tr style='height:27.4pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:27.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:27.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of children under two (0-23 months) reached with
  community-level nutrition interventions through USG-supported programs</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:27.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:27.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>147,800</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:27.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>750</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:27.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>7,776</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:27.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>65,517</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:27.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>33,049</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:27.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>107,092</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:27.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Community
  level interventions were prioritized during the year to bridge performance
  gaps through scale-up of the proven community level activities in all
  districts. A total of 107,092 (49,023male, 58,069female) children 0-23months
  were reached with essential nutrition actions (ENAs) at community level
  through VHTs and Health Assistants, with multiple contacts. The key community
  activities included biweekly and monthly MIYCAN care group sessions, routine
  home-to-home nutrition support and health education, and appropriate
  bidirectional referrals for support.  The essential messages and actions
  promoted include ENAs, immunization/deworming on schedule, food preparation
  demonstrations, promotion of village saving and loan associations (VSLAs),
  promotion of health seeking behaviors (such as ANC, PNC attendance, facility
  delivery) and appropriate child feeding/caring practices. </span></p>
  </td>
 </tr>
 <tr style='height:3.4pt'>
  <td width="7%" colspan=2 valign=top style='width:7.32%;border:solid windowtext 1.0pt;
  border-top:none;background:#FBE4D5;padding:0in 5.75pt 0in 5.75pt;height:3.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="92%" colspan=10 valign=top style='width:92.68%;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:#FBE4D5;padding:0in 5.75pt 0in 5.75pt;height:3.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><b><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Access to sustainable water supply and sanitation improved</span></b></p>
  </td>
 </tr>
 <tr style='height:3.5pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of health facilities with improved infection prevention readiness
  scores.</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>21</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>64</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>64</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>64</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>49</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>36</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>During
  the year baseline (FY21Q1) and end line (FY21Q4) assessments were conducted
  in 64 selected high-volume facilities (10Hospitals, 18HC IVs, 36HC IIIs) to
  determine status and sustainability of facility WASH in OPD, labor/delivery,
  and postnatal units guided by the facility WASH score cards - tools that
  assess WASH in outpatient department (OPD), labor and/or delivery units and,
  postnatal clinics under 5 domains (water; sanitation; hygiene and infection
  prevention; healthcare waste; cleaning and administration). District IPC
  committees were supported to integrate facility WASH into overall COVID-19
  physical and virtual support activities. Through quarterly physical and
  virtual support, facilities were supported to identify and address WASH gaps.
  Of the 49 high-volume facilities with complete data sets, IPC improvement was
  registered in 36 facilities, surpassing the annual target (21) as facilities
  positively responded to COVID-19 prevention standard operating procedures.
  There was notable increased adherence to facility WASH practices among
  healthcare providers and use of results-based financing (RBF) to address WASH
  gaps </span></p>
  </td>
 </tr>
 <tr style='height:3.5pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of basic sanitation facilities provided in institutional
  settings as a result of USG assistance</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>7</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>3</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>3</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Construction
  of Buyinja HCIV OPD structure, Biusembatya VIP latrine and Nwandala HCIII
  maternity ward  including improvement of basic sanitation facilities that
  started in FY20 continued through FY21 due to delays caused by COVID-19
  lockdowns.</span></p>
  </td>
 </tr>
 <tr style='height:3.5pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of households with soap and water at a handwashing
  station commonly used by family members</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>40%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Annual/LQAS
  indicator</span></p>
  </td>
 </tr>
 <tr style='height:3.5pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="90%" colspan=9 style='width:90.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:3.5pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Voluntary Medical Male Circumcision – VMMC</span></b></p>
  </td>
 </tr>
 <tr style='height:3.4pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid black 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:3.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IR 1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of males circumcised as part of the Voluntary Medical
  Male Circumcision package of services</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>20,943</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>8,750</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><b><span lang=EN-GB style='font-size:9.0pt;font-family:
  "Gill Sans MT",sans-serif;color:black'>7,127</span></b></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>3,267</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>348</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>93</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Circumcised
  93% of the targeted number. The VMMC activities were greatly reduced during
  the period of 2nd wave COVID 19 upsurge and restrictions (June-August 2021)</span></p>
  </td>
 </tr>
 <tr style='height:3.4pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:3.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IR 1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of circumcised males who returned for follow up
  within 48 hours</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>66.50%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>90%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>94.3%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>96%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>96%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>91%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>95.9%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Due
  to high levels of follow up, minor problems are identified and managed early
  before complications </span></p>
  </td>
 </tr>
 <tr style='height:3.4pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:3.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IR 1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of males circumcised surgically or by medical device that
  experienced at least one moderate or severe adverse event(s) (AEs)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>277</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&lt;2%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>6 (0.07%)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:3.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>6 (0.08%)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>5 (0.2%)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>0</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>0.1%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:3.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>All
  were moderate adverse events; they were successfully managed</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IR 1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of circumcised males between 15-29 years</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>95.1%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>96% (6829/7127)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>94% (3069/3267)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>329/348
  (94.5%)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>95.2%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>All
  circumcised clients were 15 years and above </span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="90%" colspan=9 style='width:90.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>HIV prevention for Key and Priority Populations</span></b></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IR 1.3.2;</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of key populations (KPs) reached with individual and/or
  small group level HIV prevention interventions designed for the target
  population.</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>12,386</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1,598</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>4,221</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>6,091 </span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>3,550</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>(115%
  of FY21Q4 Target)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>15219
  (123% of annual target)</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>A total of 3550 KPs have been served in FY21Q4, which is a 115%
  performance against the quarterly target of 3097. The achievement is
  attributed to the proactive support given to MJAP prevention officers,
  facility and community based KP/PP teams and use of the Peer-Led approach. 
  Cumulatively 15,219 (123 % of the annual target of 12,386) has been achieved.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IR 1.3.2;</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of priority populations (PP) reached with the
  standardized, evidence-based intervention(s) required that are designed to
  promote adoption of HIV prevention behaviors and service uptake</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>9,756</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>4,177</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>8,298</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>6,060 </span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>2,766</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>(113%
  of FY21Q4 target)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>20,762
  (213% of annual target)</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>A total of 2,766 PPs were served during FY21Q4 which was a 113%
  achievement against the quarterly target (2,439). Cumulatively, 20,762 PPs
  have been served, which is a 213% achievement against the annual target of
  9,756.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>IRs 1.3 Sub-IR 1.3.2;</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>Number of individuals who were newly
  enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) to prevent
  HIV infection in the reporting period </span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>3,656</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>696</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>2,215</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1,730</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>1,176</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>6,413
  (173% of annual target)</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>During
  the quarter, 1,176 individuals were newly enrolled on PrEP which was a 128.7%
  achievement against the quarterly target of 914. Cumulatively, 6,413
  individuals have been newly enrolled on PrEP in the region. This is a 175%
  achievement against the -annual target (3,656). The good performance is
  attributed to ongoing mentorships on PrEP and integration of PrEP messaging
  into routine health education during KP/PP targeted outreaches to create
  demand for PrEP services among high risk KPs and PPs. </span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>IRs 1.3 Sub-IR 1.3.2;</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>Number of individuals, inclusive of those
  newly enrolled, that received oral antiretroviral pre-exposure prophylaxis
  (PrEP) to prevent HIV during the reporting period </span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>5,021</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1,376</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>3,719</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>2,846 </span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>2,156</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>7,318
  (167% of annual target)</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>A
  total of 2,156 individuals received antiretroviral PrEP during the quarter
  which contributed to the cumulative FY21 total of 7,318. By the end of FY21Q4,
  167% of the annual target had been achieved. The optimal performance is
  attributed to the targeted districts and health facilities support. These
  were supported to implement MMD for PrEP, conduct community PrEP refills at
  DICs and KP/PP hot spots and provide adherence support and counselling to
  PrEP clients.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'><a
  name="_Hlk70536813"></a>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red;letter-spacing:-.1pt'>&nbsp;</span></p>
  </td>
  <td width="90%" colspan=9 style='width:90.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Gender-Based Violence (GBV)</span></b></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR2.1 Sub-Irs 2.1.1, 2.1.2, 2.1.3, 2.1.4, IR 1.3 Sub-Irs 1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of people receiving post-GBV clinical care based on the
  minimum package</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;background:yellow'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>10,876</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>40% (4,390</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>76</span><span lang=EN-US style='font-size:9.0pt;font-family:
  "Gill Sans MT",sans-serif;color:black'>% (6,430)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>116% (12,609)</span></p>
  </td>
  <td width="5%" valign=top style='width:5.48%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>145%(15,915/10,876)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>145%(15,915,10,876)</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>RHITES-EC achieved 145% (15,915/10,876) of its annual GEND_GBV
  PEPFAR target. 535 GBV survivors also received and completed PEP Improvement
  interventions implemented at 81 facilities with GEND_GBV facilities in 12.The
  performance is attributed to intensified</span><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'> r</span><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>outine enquiry for IPV using screening tools through
  VHTs/Linkage facilitators/youth peers at various facility entry points and
  clinical enquiry for IPV and sexual violence</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red;background:yellow'>&nbsp;</span></p>
  </td>
  <td width="90%" colspan=9 style='width:90.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>HIV Testing Services-HTS</span></b></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IR 1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of individuals who received HIV Testing Services (HTS)
  for HIV and received their test results</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:
  "Gill Sans MT",sans-serif;color:black'>  </span></b><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>145,989</span><b><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'> </span></b></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;background:yellow'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>93,428
  (256% of FY21Q1 target)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>87,652
  (240% of FY21Q2 target)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>91,154
  (250% of FY21Q3 target)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>70,565
  (193% of FY21Q4 target)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>342,799
  (235%)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  letter-spacing:-.25pt'>Achieved 193% (70,565/36,498) of the quarterly target.
  Cumulatively the region has tested 342,799</span><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'> </span><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  letter-spacing:-.25pt'>individuals, a 235% achievement against the annual
  target of 145,989. The over-achievement of testing is mainly attributed to
  having no targets allocated to all the entry points that conduct HIV testing
  and intensified testing of siblings of children and adolescents in HIV care. </span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IR 1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of individual HIV self-test kits distributed</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:
  "Gill Sans MT",sans-serif;color:black'>  </span></b><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>10,069</span><b><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'> </span></b></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:
  "Gill Sans MT",sans-serif;color:black'>&nbsp;</span></b></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>2,574
  (102% of FY21Q1 target)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>5,864
  (233% of FY21Q2 target)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>4,655
  (185%) of the FY21Q3 target</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>1,835
  (73%) of the FY21Q4 target</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>14,924
  (148%)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  letter-spacing:-.25pt'>An achievement of 73% against the quarterly target
  (2,518). Declined performance in FY21Q4 is attributed to stock outs of HIVST
  in FY21Q3 &amp; FY21Q4. Cumulatively,14,924 HIVST kits were distributed, a
  148% achievement against the annual target (10,069). The project will
  continue monitoring the processes and provide the required support promptly. </span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IR 1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of newly diagnosed HIV-positive persons who received
  testing for recent infection with a documented result during the reporting
  period</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>5,082</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>31
  (2%)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>253
  (20% of FY21Q2 target</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>241
  (19%) of FY21Q3 target</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>200
  (16%) of FY21Q4 target</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>725
  (14%)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  letter-spacing:-.25pt'>An achievement of 16% of the quarter target (1,271)
  was attributed to rolling out Recency HIV testing to only 28 out of the 106
  sites with targets and targeting only clients identified through facility HIV
  testing. Cumulatively, 725 Asante tests were done contributing to 14%
  achievement against the 5,082. annual target. The project will continue to
  support health facility teams to improve coverage and reporting through the
  upgraded EMR.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IR 1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of individuals who were identified and tested using index
  testing services and received results</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>3,762 </span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;background:yellow'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>1,970
  (209% of FY21Q1 target)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>3,435 (365% of FY21Q2 target)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>4,302
  (457% of FY21Q3 target)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>6,608
  (703% of FY21Q4 target)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>16,513
  (434%)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  letter-spacing:-.25pt'>The region tested 6,608 individuals during FY21Q4
  using index testing model, an achievement of 703% against the quarterly
  target (941). The excellent performance is attributed to the streamlined
  implementation guided by the index Client Testing (ICT) SOP and the ICT
  tracker that improved identification of eligible index clients and eased
  follow up for ICT service initiation, KYCS &amp; integration of index testing
  in caregivers’ meetings, improving the scope of index testing to reach out to
  exposed children and siblings of CALHIV and the Paediatric and /adolescent
  collaborative. Cumulatively a total of 16,513</span><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'> </span><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  letter-spacing:-.25pt'>individuals have been tested using the index testing
  approach which is a 434% achievement against the 3,762 annual target.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IRs 1.3.1 and 1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of individuals who received HIV Testing Services (HTS)
  and positive test results</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1,421 </span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>1,912
  (358% of FY21Q1 target)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>1,987
  (559% of FY21Q2 target)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>2,107
  (594%) of FY21Q3 target</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>1,304
  (367%) of FY21Q4 target</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  letter-spacing:-.25pt'>7,310 (514%</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  letter-spacing:-.25pt'>A total of 1,304 individuals were newly diagnosed HIV
  positive during the quarter which was a 367% achievement against FY21Q4
  targets (355) and a cumulative 514% achievement against the 1,421-annual
  target. The good performance is mainly attributed to intensified implementation
  of index testing and effort to use screening tools. Significant numbers of
  positives came from the OPD section 51% (3,703/7,310) where huge volumes of
  tests were done (166,326) and brought in more than targeted positives despite
  the low yield of 2%.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IR1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of newly identified HIV positives who were linked
  into HIV care services</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&gt;95%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>95%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>93%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>93%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>95%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>94%</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  letter-spacing:-.25pt'>Linked 95% of newly identified HIV positives to care
  and treatment. Linkage in FY21Q4 achieved the 95% linkage target. Cumulatively
  linkage fell short of the 95% linkage target by 1%. The most common reason
  behind un-linked clients is refusal to start ART immediately by the client.
  Teams will be supported to improve quality of pre and post-test counselling
  as a way of improving the treatment acceptance rates and improving client
  self-management. Linkage facilitators will be attached to individual clients
  to improve tracking and follow up of all non-linked clients.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="90%" colspan=9 style='width:90.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Prevention of Mother to Child Transmission &amp; Early Infant
  Diagnosis</span></b></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.15pt'>IRs 1.3 Sub-IRs 1.3.1 and 1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of pregnant women with known HIV status at ANC (includes
  those who already knew their HIV status prior to ANC)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>95%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>98.2%</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>32,923/33,512</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>98.7% 37074/37548</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>98.7%</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>34,053/34,500</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>92.6% 28,829/31,136</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>97.2% 132,879/136,696</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Annual performance was maintained at  from 97.2% in FY20
  compared to FY20, Performance, however, declined  from 98.7% in FY21Q3 to
  92.7% in FY21Q4 due to stock out of HIV testing kits at facilities. This was
  attributed to delay in Cycle 1 commodities by NMS. </span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Achieved annual performance is 102% of the annual target. This
  was contributed by PMTCT outreaches to HCIIs and triaging mothers to test for
  HIV before ANC consultation at health facilities.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>RHITES-EC will continue to support HCIIs to provide HIV testing
  services through PMTCT outreaches while maintaining gains on HIV testing at
  higher level health facilities. HIV Testing kits will be redistributed to
  health facilities with low stocks by the district Medicine Management Supervisor
  (MMS). Targeted community outreaches will be organized for mothers that have
  not received HIV testing services at facility with specific focus to Buyende,
  Mayuge, Namayingo, Bugiri and Kaliro districts where we experienced HIV
  testing kits stock outs in the quarter. </span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.15pt'>IRs 1.3 Sub-IRs 1.3.1 and 1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of pregnant women with positive HIV status at ANC</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>92%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>     3,434 </span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1,036</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1131</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1049</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>992</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>4,138</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Optimal Annual Performance at 120 %(4,138/3,434) of the target
  compared to 77.3% in FY20 was due to increased testing. RHITES-EC will
  continue to support implementation of HIV testing in ANC at both facility and
  community with intensified support to HC IIs to identify all HIV positive
  women and mentoring staff on Re-testing of mothers during ANC, Labour and
  PNC.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.15pt'>IRs 1.3 Sub-IRs 1.3.1 and 1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of HIV-positive pregnant women who received ART to
  reduce the risk of mother-to-child-Transmission (MTCT) during pregnancy</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>95%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>101 %</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>(1043/1036)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>99% 1120/1131</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>99%</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1038/1049</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>101.3% 992/979</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100 %</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>4193/4195</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Proportion of mothers initiating ART increased to 101.3% this
  quarter from 99% in FY20Q3. This culminated the annual performance at 100%,
  an increase from 96.1% in FY20. During FY20Q4,  HC IIs had ART initiation of
  90.3% compared to 88.7% from FY20Q3. Efforts to ensure 100% ART initiation
  include proactive follow-up of HIV positive mothers that have declined ART,
  community initiation of ART(at home), physical referral of Newly identified
  HIV positive mothers to PMTCT accredited sites for care and treatment,
  supporting HCIIs with ART starter packs for timely ART initiation and monthly
  data cleaning.    HC IIs with targets had ART initiation of 100%. Efforts to
  maintain 100% ART initiation include proactive follow-up of HIV positive
  mothers that have declined ART, community initiation of ART (at home),
  physical referral of Newly identified HIV positive mothers to PMTCT
  accredited sites for care and treatment, supporting HCIIs with ART starter
  packs for timely ART initiation and monthly data cleaning.   </span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.15pt'>IRs 1.3 Sub-IRs 1.3.1 and 1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of infants born to HIV- positive women who had a
  virologic HIV test done within 12 months of birth who tested positive for HIV</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>26 (3.0%)</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>(26/908)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>30(3.1%)</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>(30/961)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>17(1.8%)</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>(17/966)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>23(2.7%) (23/839)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>(2.6%)</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>98/3,674</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>RHITES-EC maintained the proportion of HEI testing positive at
  2.6% in FY21 compared to FY20. This is due to improvement in testing of
  mothers at all health center levels, timely linkage to ART and timely
  provision of ARV prophylaxis for low risk and high-risk HIV Exposed Infants.
  Demand creation for ARV prophylaxis has been created for the mothers during
  ANC through health education.</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>The 23/839 (2.7%) HIV positive infants registered in FY21Q4 were
  from immunization outreaches and mothers who were lost to follow up and
  returned to care. Point of care (PoC) for EID testing have reduced TAT of
  results at high volume facilities and promoted same day initiation on ART for
  the HIV positive infants. EPI/EID integration will be further strengthened
  using the testing algorithm for HEI &lt;18 months of age to screen infants in
  the community, YCC, OPD and inpatient wards and HCII integrated outreaches</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.15pt'>IRs 1.3 Sub-IRs 1.3.1 and 1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of infants born to HIV- positive women who had a virologic
  HIV test done within 12 months of birth</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>90%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>84.0%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>908/1079</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>83% 961/1158</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>89.9%</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>966/1075</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>83.9%</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>839/1000</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>85.2%</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>(3674/4312)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>The performance of EID coverage at 12 months has increased from
  80.5% in FY20 to 85.2% in FY21.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Performance will be further improved through utilization of the
  HEI tracking tool to identify eligible infants for virologic HIV testing,
  strengthening EID/EPI integration at immunization/YCC clinics and outreaches,
  expanding EID access to Pediatric wards and OPD through mentorships of staff
  and use of lay testers at facilities to screen for HEI. RHITES-EC will
  support LPHS-EC on community EID testing that started in FY21 to reach all
  infants that missed their appointments. Facilities will be mentored on
  utilization of the HEI tracking tool to timely provide EID testing of HEI.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Health workers at different points of care at facilities with
  POC testing will be oriented to increase screening for HEI and support
  referral of EID PCR samples for testing to increase utilization of EID POC
  machines.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.15pt'>IRs 1.3 Sub-IRs 1.3.1 and 1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of final outcomes among HIV exposed infants
  registered in the birth cohort</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>95%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>89.3% 837/937</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>90.4% 946/1046</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>93.1%</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>864/928</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>96%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>971/1012</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>92.2%
  3621/3926</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Final outcomes for HEI registered in the birth cohort increased
  from 90.4% in FY21Q3 to 96% in FY21Q4 with an annual performance of 92.2% in
  FY21 compared to 87% in FY20.</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'> This will be further improved through active follow-up of
  mother-baby pairs by the linkage facilitators/mentor mothers and adherence to
  the EID services in the treatment cascade with emphasis on Kamuli, Iganga
  districts and Jinja City that performed below 95% in FYQ4 birth cohort
  monitoring of the HEI. Mother baby pairs will be assigned to a specific
  linkage facilitator/mentor for follow up at the health facility and home.</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Facilities will be supported to document in the BBMB tools for
  easy tracking of mothers and HEI that are lost. Mother baby pairs from
  facilities will be attached to parish-based mentor mothers from Mother to
  mother for home follow-up in ART adherence and timely EID tests.</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.15pt'>IRs 1.3 Sub-IRs 1.3.1 and 1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.15pt'>Percentage of HIV+ infants from EID
  enrolled on ART</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.15pt'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.15pt'>95%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>96% 25/26</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>96.6%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>29/30</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>118%</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>20/17</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100% 23/23</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>101%</span></p>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:0in;margin-top:
  0in;text-align:justify;line-height:normal'><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>99/98% </span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Annual performance of Proportion of HIV+ infants from EID
  enrolled on ART was at 101% in FY21 compared to 97% in FY20. All infants were
  initiated on ART in FY20. RHITES-EC will continue to solicit for line lists
  of positive infants from CPHL and use them to follow-up infants at facility
  and community level to ensure timely ART initiation. Root cause of
  sub-optimal performance in previous quarters at facilities is non-disclosure
  to partners and parents’ religious beliefs.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>RHITES-EC will support facilities to closely follow-up high risk
  infants and provide timely ART initiation for HIV positive infants with
  improved TAT of results through utilization of EID POC machines.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red;letter-spacing:-.15pt'>&nbsp;</span></p>
  </td>
  <td width="90%" colspan=9 style='width:90.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>HIV Care and Treatment Services</span></b></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IRs 1.3.1 and 1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of adults and children newly enrolled on antiretroviral
  therapy (ART)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1,326</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1,847</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>2,213</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>2,039</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>1,505</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>7,604</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>The
  project has cumulatively achieved 574% of its annual target of TX_NEW. The
  good performance is attributed to site and district support for
  implementation of efficient HIV testing modalities and closing linkage gaps
  onto ART for the newly tested HIV positive clients. </span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IRs 1.3.1 and 1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of adults and children currently receiving antiretroviral
  therapy (ART)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>65,530</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>59,522</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>60,880</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>61,840</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>62,128</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>62,128</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>There
  was an increment of clients receiving ART from 61,840 at the end of FY21Q3 to
  the current 62,128 (95%) by end of FY21Q4. The project supported
  interventions for increased identification of new HIV positives, their
  enrollment on ART and closing gaps on patient continuity on treatment
  (retention) to support achievement of the annual TX_CURR target.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><a name="_Hlk78371949"><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>IRs 1.3 Sub-IRs
  1.3.1 and 1.3.2</span></a></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Proportion of ART patients who were screened who are receiving
  TB treatment.</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>2%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0.47%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0.7%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0.5%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>0.4%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>0.4%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>The
  project supported TB prevention strategies among HIV positive clients including
  initiation and completion of TPT for eligible clients while screening all ART
  clients on each clinic visit for TB and assessing presumptive cases for TB
  diagnosis. The project will provide technical assistance to the LPHS-EC to
  continue supporting TB prevention strategies among all HIV positive clients
  while providing TB treatment to those that have active TB disease.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IRs 1.3.1 and 1.3.2, IR 3.3 Sub- IR 3.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of adults and children known to be on treatment 12
  months after initiation of ART</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>95%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>68%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>75%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>71%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>71%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>71%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Clients’
  continuation on treatment 12 months after initiation of ART remained at 71%
  by end of FY21Q4 as it was by end of FY21Q3 despite the COVID-19 prevention
  restrictions. This is attributed to undocumented patient self-transfer-outs
  and the effects of the COVID-19 prevention lockdown measures with the
  accompanying transport restrictions to clients. The project will provide
  technical assistance to the LPHS-EC activity to support implementation of
  strategies that facilitate client retention in care including: pre-clinic
  appointment reminders; daily audit of clients’ scheduled appointment keeping,
  immediate follow-up of missed appointments; community and home delivery of
  ARVs to clients unable to pick their drug refills; tracking of lost clients
  for re-engagement in care, improved quality of counseling by trained
  counselors; scale-up and implementation of DSD models including deepening
  multi-months dispensing (MMD) of ART to eligible clients; and timely updating
  of registers to inform corrective patient tracking actions.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IRs 1.3.1 and 1.3.2, IR 3.3 Sub- IR 3.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of ART patients with a VL result documented in the
  medical and/or laboratory records/LIS within the past 12 months.</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>95%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>91%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>91%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>91%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>80.5%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>80.5%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>VL
  testing coverage averaged at 80.5% by end of FY21Q4. This is attributed to
  supporting VL testing mop-up campaign and targeted VL testing of eligible
  clients at sites. There were however gaps in VL sample capture and processing
  at CPHL with VL results TAT longer than the recommended maximum of 21 days
  which has negatively affected the overall VL testing coverage. The project
  will work with CPHL and the Laboratory hub system to track all client samples
  whose results have not been received at the sending hubs/sites. </span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IRs 1.3.1 and 1.3.2, IR 3.3 Sub- IR</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of ART patients with a viral load result documented
  in the medical record and/or laboratory information systems (LIS) within the
  past 12 months with a suppressed VL (&lt;1000 copies/ml)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>95%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>90%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>86%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>88%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>92%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>92%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>There
  was improvement in VL suppression from 88% at the end of FY21Q3 to 92% at end
  of FY21Q4 as per the CPHL raw data download. This is attributed to  on-site
  mentorships, coaching and support supervision on ART treatment optimization,
  engagement of experienced clinicians and counselors to provide high quality
  clinical care and adherence counseling especially to the non-suppressed
  clients, implementation of appropriate DSD models to support continuity on
  treatment and VL suppression, scale-up of MMD for eligible clients, special
  clinics for the virally non-suppressed clients to offer tailored service
  packages to them, timely switching of eligible non-suppressed clients to
  optimal regimens, and support to district and site teams on implementation of
  the national paediatric and adolescent HIV care improvement collaborative. </span><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>The
  project will provide Technical Assistance (TA) to the LPHS-EC activity to
  deepen partnerships with USAID supported OVC partners like USAID/ICARE and
  ICYD to provide psychosocial support and counselling services to all children
  and adolescents in care to support and enhance their adherence to care and
  continuity on treatment.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IR1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of ART patients (who were on ART at the beginning of the
  quarterly reporting period) and then had no clinical contact since their last
  expected contact</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>NA</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>PEPFAR to set target</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1,029</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>958</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>975</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>1,024</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>3,986</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>The
  project supported health facility and district teams to line list all clients
  with no clinical contact during the quarter for follow-up to bring them back
  and re-engage them in care. Phone and Physical follow-ups involving
  counsellors, facility and community volunteers will be further facilitated
  and supported by the LPHS-EC activity to bring back these clients and
  re-engage them in care including assessment for and provision of various
  services along the HIV quality care cascade. This will be accompanied by
  corresponding documentation and updating of respective data tools to account
  for every client.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IR1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of ART patients with no clinical contact (or ARV drug
  pick-up) for greater than 28 days since their last expected contact who
  restarted ARVs within the reporting period</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>NA</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>PEPFAR to set target</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>431</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>368</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>543</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>401</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>1,743</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>401
  clients restarted ARVs within the reporting period after being followed-up.
  RHITES-EC supported and facilitated efforts to bring back lost clients for
  re-engagement into care through patient tracking and follow-up mechanisms
  using both facility and community structures. Reasons for dropping out of
  care were documented for programming to prevent patient losses. Good and
  promising practices in client follow-ups were documented for continuous
  application and refining to further prevent and address patient loses. The
  project will provide TA to the LPHS-EC activity to continue supporting and
  facilitating these efforts for improved program performance.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>CXCA_SCRN</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>8,327</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>0</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>0</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>236</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>127</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-GB
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>363</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>The
  EC region registered a 4% achievement against the annual target. Screening
  started late and it was interrupted during the FY21Q3 and FY21Q4 by COVID-19
  surge in the region and late delivery of key supplies. RHITES-EC will provide
  TA to the LPHS-EC activity to intensify activities and strategies to catch-up
  with the unmet need for the services.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>CXCA_SCRN_POS</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'> 
  </span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>0</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>0</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>10</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>8</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-GB
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>18</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>The
  region registered a 5% positivity rate for pre-cancerous lesions. This
  depicts a high prevalence and the need to extend the services to all eligible
  clients to pick out those with lesions and refer them for treatment.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>CXCA_SCRN_TX</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>0</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>0</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>10</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>8</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-GB
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>18</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>All
  clients identified positive with pre-cancerous lesions were treated for the
  same, either onsite or through referral to sites with treatment services.
  RHITES-EC will provide technical assistance to the local partner health
  services-EC activity (LPHS-EC) to ensure all positive clients from screening
  are provided with treatment for the pre-cancerous lesions.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="90%" colspan=9 style='width:90.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Access to TB services increased</span></b></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IRs 1.3.1 and 1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>TB Case Notification Rate (per 100,000 people)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>92/100,000</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>156/100,000</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>110/100,000</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>119/100,000</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>141/100,000</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>112</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>118/100,000</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>During
  FY21, there was gradual improvement in CNR over the four quarters and a dip
  during FY21Q4. The improvement in TB case finding over the first 3 quarters
  is attributed to the improvements in facility level TB screening and
  community case finding through the contact tracing and outreach screening in
  congregate settings. The dip in performance during FY21Q4 is attributed to
  the 2<sup>nd</sup> wave of COVID-19 which affected implementation of
  community TB case finding activities like contact tracing and outreach
  screening.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IRs 1.3.1 and 1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>TB Case Detection Rate</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>49%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>90%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>54%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>68%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>80%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>66.8%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>69.3%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>During
  FY21, there was gradual improvement in CNR over the four quarters and a dip
  during FY21Q4. The improvement in TB case finding over the 3 quarters is
  attributed to the improvements in facility level TB screening and community
  case finding through the contact tracing and outreach screening in congregate
  settings. The dip in performance during FY21Q4 is attributed to the 2<sup>nd</sup>
  wave of COVID-19 which affected implementation of community TB case finding
  activities like contact tracing and outreach screening.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1IRs 1.3 Sub-IR 1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percent of registered new smear positive pulmonary TB cases that
  were cured and completed treatment under </span><span lang=EN-GB
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>directly
  observed treatment</span><span lang=EN-US style='font-size:9.0pt;font-family:
  "Gill Sans MT",sans-serif;color:black'>s nationally (TB Treatment Success
  Rate (TSR)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>85%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>90%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>85%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>87%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>85%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>88%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;letter-spacing:
  -.1pt'>87.5%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>There
  has been a gradual improvement in TB TSR over the four quarters of FY21,
  attributed to implementation to scale of the national TSR QI package that
  includes <a name="_Hlk86169041">monthly client retention monitoring and real
  time follow up of missed appointments and lost to follow up TB clients.</a></span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IR 1.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>TB cure rate</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>50%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>70%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>59%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>72.1%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>69%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>70%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>67.4%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  letter-spacing:-.1pt'>Cure rate improved gradually over the four quarters of
  FY21. The overall cure rate for FY21 was 67.4%, short of the 70% national
  target due to poor performance (59%) during FY21Q1. The improvement is also
  attributed to interventions in the TSR QI package.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IRs 1.3.1 and 1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of multi-drug resistant tuberculosis cases detected</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>50</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>9</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>11</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>18</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>16</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>54</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  letter-spacing:-.1pt'>The project supported the detection of 54 MDR-TB cases
  during FY21, surpassing the target of 50. This is attributed to support
  provided to improve MDR-TB surveillance at all health facilities through
  improved access to GeneXpert testing for high-risk groups and intensified
  community case findings.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IRs 1.3.1 and 1.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of multi-drug resistant tuberculosis cases that have
  initiated second line treatment</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>45</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>9</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>11</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>18</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>16</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>54</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  letter-spacing:-.1pt'>All identified DR-TB patients were started on 2<sup>nd</sup>
  line treatment at the two treatment centers in the region </span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IRs 1.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of new and relapse TB cases with documented
  HIV-positive status</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>32%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>30%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>28%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>22%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>26.8%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;letter-spacing:
  -.1pt'>26%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  letter-spacing:-.1pt'>26.8% of the notified TB patients were co-infected with
  HIV. The project supports facilities TB/HIV integrated care, and TB
  prevention services amongst HIV positive individuals.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IR 1.3.2,</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Proportion of ART patients who completed a standard course of TB
  preventive therapy within the reporting period</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>95%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>91%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>93%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>96%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>88%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;letter-spacing:
  -.1pt'>87.5%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>There
  has been a gradual improvement in TB TSR over the four quarters of FY21,
  attributed to implementation to scale of the national TSR QI package that
  includes monthly client retention monitoring and real time follow up of missed
  appointments and lost to follow up TB clients.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IRs 1.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>The number of HIV-positive new and relapsed TB cases on ART
  during TB treatment</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1,558</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>386</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>366 </span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>242</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>70%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>67.4%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  letter-spacing:-.1pt'>Cure rate improved gradually over the four quarters of
  FY21. The overall cure rate for FY21 was 67.4%, short of the 70% national
  target due to poor performance (59%) during FY21Q1. The improvement is also
  attributed to interventions in the TSR QI package.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IR 1.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of new and relapse TB cases with documented HIV
  status</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>99%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>99%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>98%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>16</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>54</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  letter-spacing:-.1pt'>The project supported the detection of 54 MDR-TB cases
  during FY21, surpassing the target of 50. This is attributed to support
  provided to improve MDR-TB surveillance at all health facilities through
  improved access to GeneXpert testing for high-risk groups and intensified
  community case findings.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="100%" colspan=12 style='width:100.0%;border:solid windowtext 1.0pt;
  border-top:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Access to laboratory services improved.</span></b></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IRs 1.3 Sub-IR 1.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percent of USG-supported laboratories performing TB microscopy
  with 95 percent or higher rate of correct results</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>16% (19)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>75% </span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>37.6% (38)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>37.6% (38)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>40.6% (40)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>40.6% (40)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>40.6%
  (40)</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>40.6% (40) Labs participated and passed on the EQA scheme for TB
  AFB (Blinded rechecking) during FY21. EQA feedback reports for FY21Q4 await
  completion of data analysis by NTRL. Targeted technical support will be
  conducted during FY22, to improve performance of laboratories on the EQA
  scheme. In addition, refresher training of laboratory staff on TB microscopy
  will be conducted during FY22, to improve performance of Laboratories at all
  TB Diagnostic Units.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 3.3 Sub-IR 3.3. 4</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of hub laboratories that have attained a 3 Star status,
  on the WHO/SLIPTA laboratory accreditation preparedness checklist.</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>9</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>4</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>5</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>5</span></b></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>5</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>5</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Five of nine Laboratory hubs attained the 3 SLIPTA Star target;
  Jinja RRH (4 Stars), Buyinja HCIV (4 Stars), Masafu GH (3 Stars), Iganga GH
  (3 Stars), and Bumanya HCIV (3 Stars). Four laboratory hubs that performed
  below the target of 3 stars (Kidera HCIV, Kigandalo HCIV, Bugiri GH and
  Kamuli GH), will be supported to improve their quality management systems
  through regular scheduled onsite mentorships.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 3.3 Sub-IR 3.3. 4</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of laboratories and blood banks/centers engaged in
  continuous quality improvement (CQI) activities.</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>11</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>101</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>101</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>101</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>101</span></b></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>101</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>101</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>101 Laboratories participated in CQI activities. That includes 1
  Laboratory hub (Jinja RRH) that is implementing the SANAS international
  accreditation process, 8 Laboratory hubs that are implementing the SLMTA
  program, and 92 Lower health facility Laboratories that are implementing
  LQMS.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 3.3 Sub-IR 3.3. 4</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of laboratories and blood banks/centers audited and
  achieved accreditation</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>2</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1</span></b></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black;
  letter-spacing:-.1pt'>1</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;letter-spacing:-.1pt'>Jinja RRH attained international
  accreditation by SANAS during FY21. Iganga GH will be fast tracked to attain
  international accreditation during FY22.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 3.3 Sub-IR 3.3. 4</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of laboratories and blood banks/centers performing
  HIV-related test and participating in and passing proficiency testing (PT)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>60</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>250</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>177</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>242</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>250</span></b></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>250</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>250</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>The pass rate on the HIV Proficiency Testing (PT) scheme during
  FY21Q4 was 93.8%, giving an average of 94.6% during FY21, against the target
  of 100%. A total of 250 HIV testing sites, including 100 laboratory sites and
  150 POCT sites participated in and passed on HIV PT. Performance below target
  was attributed to failed tests, and ungraded test results due to incomplete
  documentation. To improve on the performance, targeted EQA technical support
  will be conducted during FY22, focused on improving documentation and
  reporting of test results and the required information.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 3.3 Sub-IR 3.3.4</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of Viral load (VL) specimens rejected by the national
  VL testing laboratory at MoH/CPHL</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>3.90%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1.00%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0.37%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0.43%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0.8</span></b></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1.03%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>0.8%</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>The average VL specimen rejection rate during FY21 was 0.7%,
  against the target of &#8804;1%. The relatively high rejection rate in FY21
  FY21Q4  was attributed to hemolysis of whole blood specimens from peripheral
  ART sites during transportation. We are procuring additional centrifuges for
  high volume ART sites (20), to facilitate centrifugation of whole blood
  specimens for plasma separation before transportation.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 3.3 Sub-IR 3.3.4</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>GeneXpert equipment utilization</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>7</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>10</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>5.2</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>5.0</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>6.0</span></b></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>3.0</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'> 6.0</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>A total of 23405 GeneXpert tests were performed during FY21,
  giving an average GeneXpert utilization of 4.3 samples/day, against the
  target of 12 samples/day.  Performance below target was majorly attributed to
  a decline in patient attendance during the COVID-19 lockdown period, and
  occasional breakdown of GeneXpert modules at some sites (Kiyunga HCIV and
  Bumanya HCIV). </span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 3.3 Sub-IR 3.3.4</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of PEPFAR-supported laboratory-based testing and/or
  Point-of-Care Testing (POCT) sites engaged in CQI and proficiency testing
  (PT) activities.</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>11</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>300</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>196</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>311</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>311</span></b></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>311</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>311</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>A total of 311 HIV testing sites participated in CQI activities
  (EQA for HIV tests), including 124 laboratory sites and 187 POCT sites.
  Performance above targets was attributed establishment of additional
  Point-of-Care HIV Testing sites at HCIIs under the PMTCT program.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:
  "Gill Sans MT",sans-serif;color:red'>&nbsp;</span></b></p>
  </td>
  <td width="90%" colspan=9 style='width:90.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>National Quality Improvement (QI) Framework operationalized</span></b></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 3.3 Sub-IRs 3.3.1, 3.3. 5 and 3.3.6</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Proportion of supported health facilities (HCIIIs and above)
  with functional QI committees</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>62.8%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>84% (126/150)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>84% (126/150)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>(87%)</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>107/122</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>87%(107/122)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>85.5%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>This
  has been achieved through Integrating support on QI committee functionality
  during the Monthly Pediatric HIV Mentorship.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><a name="_Hlk70538369"><span lang=EN-US style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>IR 3.3 Sub-IRs 3.3.
  5 and 3.3.6, IR 3.1 Sub-IRs 3.1., 3.1.2</span></a></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Proportion of supported districts with functional QI committees</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>11</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100% (12/12)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100% (12/12)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>12/12</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%(12/12)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>100%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>All
  12 District QI committees are fully Function with Assigned Quality
  Improvement Focal Persons that Submit Quarterly functionality Assessments to
  the Regional QI Committee.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 3.3 Sub-IR</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>3.3.43.3.6</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of health facilities scoring at least 2 stars on the
  Ministry of Health facility quality of care assessment program (HFQA)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>30%</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>35% (52/150)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>35%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>This
  activity  is conducted as an annual Assessment by District Supervisory teams
  with support from RHITES-EC.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 3.3 Sub-IRs 3.3.1, 3.3. 5 and 3.3.6</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of districts with quality planning process (i.e. with
  evidence of using data for decision making)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>100%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>All
  districts Have used this Data according to the Local Government Planning
  Process and District Performance review Meetings.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 3.3 Sub-IRs 3.3.1, 3.3. 5 and 3.3.6</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of men and women who say health service delivery in
  public health facilities has improved in the last year</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>81.2%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>95%</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>NA</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>NA</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:red'>&nbsp;</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>This
  assessment was not conducted in the year.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'><a
  name="_Hlk78475205"></a>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="90%" colspan=9 style='width:90.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Quality of health services improved through renovations</span></b></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 3.3 Sub-IRs 3.3.1,</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of health service delivery units renovated</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>No baseline</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>8</span></p>
  </td>
  <td width="6%" valign=top style='width:6.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>3</span></b></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>3</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Only 3 health facilities were considered for renovation upgrades
  namely Nawandala HCIII Maternity, Busembatia HCIII VIP Latrine construction
  and completion of OPD block at Buyinja HCIV;</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>-latrine construction completed and handed over to the users.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>-Practical Completion of Buyinja OPD block achieved and handed
  over to the users</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>-Completion of Nawandala HCIII maternity was affected largely by
  the prevailing covid-19 situation.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>-A further extension was granted to allow for smooth completion
  of outstanding finishing works. Practical completion is expected by
  mid-November 2021.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'><a
  name="_Hlk70538582"></a>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red;background:yellow'>&nbsp;</span></p>
  </td>
  <td width="90%" colspan=9 style='width:90.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Increased recruitment, retention &amp; management of the Health</span></b></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red;background:yellow'>&nbsp;</span></p>
  </td>
  <td width="90%" colspan=9 style='width:90.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Functionality of human resources systems improved</span></b></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 3.1 Sub-IRs 3.1.1, IR 3.3 Sub- IR 3.3. 6</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of approved personnel posts filled by qualified
  health workers</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>69%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>76%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>73.9%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>72%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>73%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>73%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>73%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Due
  to limited wage and increasing upgrade of health facilities, the staffing
  levels has not significantly improved. However, due expeditiously replacement
  recruitment, has kept it from degenerating further.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 3.1 Sub-IRs 3.1.1, IR 3.3 Sub- IR 3.3. 6</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Health worker absenteeism rate</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>13.7%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>5% </span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>55%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>29%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>NA</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>24%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>24%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>The
  iHRIS system has not been stable due to the ongoing system upgrades.
  Therefore, the stated rates are not representative of all facilities and
  health workers.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 3.1 Sub-IRs 3.1.1, IR 3.3 Sub- IR 3.3. 6</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percent of health workers with performance plans</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>80%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>NA</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>NA</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>NA</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>NA</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>N/A</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>N/A</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>No routine data source. Moving forward, this shall be integrated
  into routine HMIS data collection from individual personnel files.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 3.1 Sub-IRs 3.1.1, IR 3.3 Sub- IR 3.3. 6</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Number of health workers who are working on HIV-related
  activities and are receiving any type of support from PEPFAR, as well as
  total spend on these workers</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>NA</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>PEPFAR to set target</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>944</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1188 ($1,571,100)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>1094 ($344,940)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>1108</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>($2,501,011)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>1108</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:red'>&nbsp;</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Consistent
  with USAID guidelines, all lay workers where paid a minimum of $50. All
  seconded workers have been successfully transitioned to the LPHS Activity </span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;background:yellow'>&nbsp;</span></p>
  </td>
  <td width="90%" colspan=9 valign=top style='width:90.54%;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Reduced stock out rates of affordable medicines and health
  supplies and improved rational use of these drugs.</span></b></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'><a
  name="_Hlk78457224"></a>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red;background:yellow'>&nbsp;</span></p>
  </td>
  <td width="90%" colspan=9 valign=top style='width:90.54%;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Sub-IR 3.2.1: Access to essential medicines and supplies
  strengthened.</span></b></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><a name="RANGE!A4"><span lang=EN-GB style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>IR 1.3, Sub-IR
  1.3.1,</span></a></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Average stock out rate of ITNs at healthcare facilities</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>60%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>10%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>19.70%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;59%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;50%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>20%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-GB
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>37.2%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Supply of ITNs during FY21Q4 decreased the stock out rate by
  30%.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><a name="RANGE!A5"><span lang=EN-GB style='font-size:
  9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>IR 1.3, Sub-IRs
  1.3.1</span></a></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Average stock out rate of mRDTs at healthcare facilities</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>45%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>10%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>14.90%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>23%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>27.1%&nbsp;</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>18%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-GB
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>20.8%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Delivery of NMS Cycle 1 deliveries coupled with the honouring of
  back orders contributed to a 9.1% decrease in stock outs by end of FY21Q4.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 1.3,   Sub-IRs 1.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Average stock out rate of Coartem at healthcare facilities</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>44%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>10%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>18.30%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>25%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>27.5%&nbsp;</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;19%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-GB
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>22.5%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Delivery of equivalent quantities of AL 6x4 for AL 6x2 and AL
  6x3 during FY21Q4 greatly contributed to an 8.5% decrease in stock outs.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 1.3,   Sub-IRs 1.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Average stock out rate of Fansidar at the healthcare facilities</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>51%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>10%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>13.70%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>13%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;25.3%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>12%&nbsp;</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-GB
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>16%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Availability of central level stocks resulted in delivery hence
  availability at health facilities, during FY21Q4 thus contributing to 13.3%
  decrease in stock outs</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=ES style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 2.1, Sub-IRs 2.1.2., IR 3.3 Sub-IR 3.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><a name="RANGE!C9"><span lang=EN-GB style='font-size:9.0pt;
  font-family:"Gill Sans MT",sans-serif;color:black'>Average stock out rate of
  contraceptive commodities at FP service delivery points</span></a></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>10%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>0%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>17.30%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>30%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>46.6%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>26%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-GB
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>30%</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>The district orders placed through Alternative Distribution
  Strategy (ADS) were honoured resulting in a 20.6% decrease in stock outs. By
  end of FY21, availability of Male condoms is at 100%; IUDs (99%); Implanon
  NXT (99%); Sayana Press (90%); Depo-Provera (72%).</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="90%" colspan=9 style='width:90.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Reduced stock out rates of affordable medicines and health
  supplies and improved rational use of these drugs.</span></b></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="90%" colspan=9 style='width:90.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Sub-IR 3.2.1: Access to essential medicines and supplies
  strengthened.</span></b></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 3.3 Sub-IRs 3.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of health facilities with all the national
  recommended 41 vital essential medicines available on the day of the
  assessment.</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>90%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>80%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>76.8%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>70%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;63.2%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>78%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-GB
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>72%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Only 2.4% of the tracer commodities were adequately stocked due
  to decrease in availability of malaria commodities and continued phasing out
  of TLE 600. However, there was a notable improvement in the availability of
  oxytocin (80.1%), therapeutic feed (73.3%), Artesunate (73.1%), The most
  stocked out was CD4 reagents, GeneXpert cartridges, and RHZ</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 3.3 Sub-IRs 3.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of health facilities with adequate stock of key
  commodities</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>90%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>80%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>81.80%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>82%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;80.2%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;93%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-GB
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>84.3%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>A 1.8% decrease in availability of key commodities was observed
  resulting from the continued central level stock out of TLD 90, ABC/3TC/DTG
  600/300/50mg, HIV Syphilis DUO, Statpak, and SD Bioline coupled with the
  rationing of TLE 400 in line with MoH guidelines. However, the region was
  fairly stocked with key commodities - TLD (78.2%), ABC/3TC Paed (67.9%), INH
  100mg (89.7%) to support MMD implementation.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 3.3 Sub-IRs 3.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>The number of adult and pediatric ARV bottles (units) dispensed
  by ARV drug category at the end of the reporting period</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>PEPFAR to set target</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>238,748</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>190,031&nbsp;</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;139,561</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-GB
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>142,926</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>By end of FY21Q4, each patient had been dispensed drugs for only
  (139,561/62,128) 2.3 months; this was due to the delay in the Cycle 1 NMS
  deliveries</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 3.3 Sub-IRs 3.3.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>The current number of ARV drug units (bottles) at the end of the
  reporting period by ARV drug category</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>PEPFAR to set target</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>N/A</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>285,007</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>745,192&nbsp;</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>614,086&nbsp;</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-GB
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>548,095</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Averagely, (548,095/62,128) 8 Months of Stock were available for
  every patient during FY21. By end of FY21Q4, each patient averagely had
  (614,086/62,128) 9.9 Months of Stock thus sufficient stocks for
  implementation of MMD</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="90%" colspan=9 style='width:90.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Information management, accountability and evidence-based
  decision making at districts, facilities, and communities</span></b></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>R 3.3 Sub-IRs 3.3.5</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percent completeness of health facility HMIS 105, HMIS 106a, and
  HMIS 108 reporting</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>95%, 80%, 80%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>99%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>94%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>88%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>99%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>95%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>89%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>99%</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>96%</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>88%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>99%</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>99%</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>87%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>99%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>96%</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>87%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>DHIS2 has been stable for most of the time during the quarter
  except during peak periods of data entry. RHITES EC will support the LPHS-EC
  to sustain the high reporting rates.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="90%" colspan=9 style='width:90.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Capacity for management of decentralized service delivery in
  target districts strengthened</span></b></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="90%" colspan=9 valign=top style='width:90.54%;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:#F7CAAC;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Planning and coordination of decentralized services strengthened</span></b></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 3.1, Sub-IR 3.1.1 and 3.1.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of districts that have implemented at least 80% of
  the planned district implementing partners’ coordination activities</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>No data</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>80%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-GB
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>100%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>All Districts were able to engage with their implementing
  partners through our Bi-weekly and quarterly virtual meetings.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>IR 3.1, Sub-IR 3.1.1 and 3.1.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Percentage of districts with quality planning process (i.e. with
  evidence of using data for decision making)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>No data</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>100%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-GB
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'>100%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>We supported all districts to review performance through quarterly
  virtual performance and annual work planning meetings</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;background:yellow'>&nbsp;</span></p>
  </td>
  <td width="90%" colspan=9 style='width:90.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Intermediate Result 5.1: Knowledge, awareness, attitudes, and
  practices about key health issues improved</span></b></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black;background:yellow'>&nbsp;</span></p>
  </td>
  <td width="90%" colspan=9 style='width:90.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Sub-IR 5.1.1. Community structures strengthened to support implementation
  of interventions that promote positive social behaviors</span></b></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>IR3.3,
  Sub-IR 3.3.6, IR 1.1, Sub-</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>IR
  1.1.1,1.1.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Score
  in percent of combined areas of capacity building amongst the Civil Society
  Organizations (CSO) to promote positive social behaviors</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>NA</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>80%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>89.5%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>89.5%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>91%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>N/A</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>90%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Through
  the project’s sub-granting mechanism, we conducted annual organizational
  capacity and risk assessments for 8 CSOs which achieved an average score
  point of 89.5% in combined capacity areas (Governance&amp; legal status,
  finance &amp; administration, monitoring and evaluation, procurement
  systems). Consequently, 6 CSOs were funded in FY21. The 6 sub-granted CSOs
  received virtual mentorship to mobilize communities to promote positive
  social behaviors and increase access and utilization of health services. </span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>IR3.3,
  Sub-IR 3.3.6, IR 1.1, Sub-</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>IR
  1.1.1,1.1.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Score
  in percent of combined key areas of capacity building amongst selected
  community structures to promote positive social behaviors.</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>NA</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>50%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>97%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>86.2%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>90%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>87.5%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>90.2%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>The
  project worked with 1,296 community volunteers, that were mentored on the
  various mobilization skills, these included, Para social workers, peer
  educators, expert clients, VHTs and linkage facilitators, 945,925 community
  members were mobilization for uptake of various available services</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>IR3.4,
  Sub-IR 3.4.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Percentage
  of clients referred from the community to the health facility and received
  the service they were referred for at the facility during the reporting
  period</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>NA</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>96%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>83%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>91.5%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>92%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>81%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>87%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Working
  through the various community structures (CSOs, Linkage Facilitators, peers),
  bi-directional referrals for health and community services were conducted
  between facilities and communities. In this FY, 177,798 individuals were
  referred to health facilities, of whom 87% (154,334) received services they
  were referred for. </span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>IR3.4,
  Sub-IR 3.4.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Percentage
  of clients referred from the health facility to the community and received
  the services they were referred for during the reporting period</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>NA</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>80%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>83.3%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>84.5%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>90.1%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>86%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>86%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Individuals
  referred from health facilities to communities and received the services they
  were referred for were 86% (14,560/16,838) overall. Services clients were
  referred for include: OVC community support, psychosocial support, economic
  strengthening etc.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="90%" colspan=9 style='width:90.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Interventions that address gender and socio-cultural barriers to
  adoption of positive health behaviors implemented</span></b></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>IR3.3,
  Sub-IR 3.3.6, Joint Sub- IR 1.X.1, IR 2.1, 2.1.1, 2.1.4</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Percentage
  of planned interventions conducted to address gender and socio-cultural
  barriers to adoption of positive health behaviors</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>NA</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>90%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>90%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>90%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>55.5%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>60%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>73.8%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Conducted
  social dialogue sessions to address gender gaps and norms. In addition, targeted
  coaching and mentorship was conducted reaching 225 service providers
  (counsellors, linkage facilitators and youth peers) at 44 heath facilities in
  12 EC districts with knowledge and skills on case identification and post GBV
  care services such as inadequate GBV screening for adolescents in ART and
  PMTCT settings.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>IR1.3,
  Sub-IR 1.3.1</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Percentage
  of HIV clients in the community refill model that received ARV refills during
  the reporting period</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>0</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>95%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>100%</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>100%</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>100%</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>93%</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>98.2%</span></p>
  </td>
  <td width="24%" valign=top style='width:24.32%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'> </span><span lang=EN-US style='font-size:9.0pt;font-family:
  "Gill Sans MT",sans-serif'>We supported health facility teams (CCLAD leaders,
  linkage facilitators, adolescent peers and OVC partner community structures)
  to enroll stable clients to community ART distribution models (CCLAD and
  CDDPs). In this FY, we supported health facilities to form 3,039 CCLAD groups
  serving 9,896 clients. Across the quarters, 861, 1009, 1169 CCLAD groups
  serving 3873, 4481, 5542 in FY21Q1, FY21Q2, FY21Q3 were formed respectively.
  Health facilities were supported to distribute ART to clients living in
  hard-to-reach communities through 194 CDDP points (Q1:69, FY21Q2: 57,
  FY21Q3:68) where 4,802 clients (Q1:2305, FY21Q2:1,945, FY21Q3:5542) were
  served. Due to COVID-19 movement restrictions several clients failed to
  access facilities for their ART refills, to avert these would be losses, the
  project deployed volunteers to conduct home ART delivery to 29,009 clients.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>IR1.3,
  Sub-IR 1.3.</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Number
  of people reached by a USG funded intervention providing GBV services (e.g.,
  health, legal, psycho-social counseling, shelters, hotlines, other)</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>No
  data</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>10,876</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>40%
  (4,390)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>76</span><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>%
  (6,430)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>116% (12,609)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>116%</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>(12,609)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>116%</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>The number of people who received post their homes -GBV clinical
  care based on the minimum package of services were 116% (12,609/10,876). The
  performance is attributed to intensified</span><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;color:black'> r</span><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>outine enquiry for IPV using screening tools through
  VHTs/Linkage facilitators/youth peers at various facility entry points and
  clinical enquiry for IPV and sexual violence</span><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>.</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>IR1.3,
  Sub-IR 1.3.</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Number
  of persons trained with USG assistance to advance outcomes consistent with
  gender equality or female empowerment through their roles in public or private
  sector institutions or organizations</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>No
  data</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>405</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>360
  (88%)</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>38
  (94%)</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>225
  (55.5%)</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>312</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>(77%)</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-GB style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>234</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-GB
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>(58%)</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><a name="_Hlk70181577"><span lang=EN-US style='font-size:9.0pt;
  font-family:"Gill Sans MT",sans-serif'>Conducted targeted coaching and
  mentorship reaching 225 (M: 82 and F:143) service providers (counsellors,
  linkage facilitators and youth peers) at 44 heath facilities in 12 EC
  districts </span></a><a name="_Hlk77611319"><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>to address gaps
  on case identification and post GBV care services such as inadequate GBV
  screening for adolescents in ART and PMTCT settings. Service providers were
  mentored on active screen for GBV to identify clients who experienced
  violence based on presenting conditions, signs and symptoms of violence and
  respond appropriately</span></a><span lang=EN-US style='font-size:9.0pt;
  font-family:"Gill Sans MT",sans-serif'>.</span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'> 
  <a name="_Hlk69940035">  </a></span></p>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:red'>&nbsp;</span></p>
  </td>
  <td width="90%" colspan=9 style='width:90.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><b><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif;
  color:black'>Knowledge, awareness attitude and practices about key health
  issues improved</span></b></p>
  </td>
 </tr>
 <tr style='height:23.25pt'>
  <td width="9%" colspan=3 style='width:9.46%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>IR3.4,
  Sub-IR <br>
  3.4.1</span></p>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=PT style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>IR1.3,
  Sub-IR 1.3.1, IR 3.2 Sub- IR 3.2.1 and 3.2.2</span></p>
  </td>
  <td width="18%" style='width:18.62%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Number
  of the targeted population reached with individual and/or small group level
  HIV prevention interventions that are primarily focused on abstinence and/or
  being faithful, and are based on evidence and/or meet the minimum standards
  required</span></p>
  </td>
  <td width="7%" style='width:7.74%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>No
  data</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>1,800</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>2,887</span></p>
  </td>
  <td width="6%" style='width:6.2%;border-top:none;border-left:none;border-bottom:
  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.75pt 0in 5.75pt;
  height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
  line-height:normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>1,098</span></p>
  </td>
  <td width="6%" style='width:6.86%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>448</span></p>
  </td>
  <td width="5%" style='width:5.48%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>1,004</span></p>
  </td>
  <td width="8%" style='width:8.94%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:0in;
  margin-top:0in;text-align:center;line-height:normal'><span lang=EN-US
  style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>5,437</span></p>
  </td>
  <td width="24%" style='width:24.32%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.75pt 0in 5.75pt;height:23.25pt'>
  <p class=MsoNormal style='margin-bottom:0in;text-align:justify;line-height:
  normal'><span lang=EN-US style='font-size:9.0pt;font-family:"Gill Sans MT",sans-serif'>Reached
  adolescents during the dialogues during dialogue and Stepping-Stone sessions
  conducted by 6 CSOs in 6 districts. Adolescents were equipped with key
  information on unplanned pregnancy prevention, HTS, FP and other services
  using Reproductive Health Uganda’s audio-visual cards.</span></p>
  </td>
 </tr>
 <tr height=0>
  <td width=66 style='border:none'></td>
  <td width=7 style='border:none'></td>
  <td width=21 style='border:none'></td>
  <td width=114 style='border:none'></td>
  <td width=69 style='border:none'></td>
  <td width=74 style='border:none'></td>
  <td width=121 style='border:none'></td>
  <td width=112 style='border:none'></td>
  <td width=112 style='border:none'></td>
  <td width=104 style='border:none'></td>
  <td width=121 style='border:none'></td>
  <td width=145 style='border:none'></td>
 </tr>
</table>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

</div>

</body>

</html>





<a href="{% static 'reports_sites_2020_to_2021.pdf' %}">Click here to Download this report in PDF</a>
{% endblock %}